data_1ldr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ldr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.506 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.88 -165.41 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.451 -1.029 . . . . 0.0 109.293 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -172.99 109.14 0.18 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.6 p -68.54 120.28 14.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 28.5 t -49.28 -65.4 0.57 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 110.833 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.36 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.4 25.89 72.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.33 72.96 0.49 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.387 -1.067 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.35 -23.6 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.052 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 p30 179.68 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.354 -0.841 . . . . 0.0 109.83 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -155.45 -175.63 5.53 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.61 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.23 175.35 6.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.669 -0.644 . . . . 0.0 109.322 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.477 ' HB ' ' CD2' ' A' ' 10' ' ' PHE . 37.8 mm -130.28 139.8 36.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.8 Cg_endo -71.06 159.1 53.39 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.414 1.409 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.35 -26.64 63.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.553 -0.717 . . . . 0.0 109.073 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.05 -39.34 83.03 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.707 -0.621 . . . . 0.0 109.484 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.528 ' CE3' ' HB2' ' A' ' 31' ' ' ASP . 11.9 m95 -81.37 -3.99 54.39 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 24.9 tpt180 -76.35 148.92 37.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.388 -1.445 . . . . 0.0 107.504 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 5.1 t 86.27 -56.32 0.06 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.47 -76.17 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.89 -18.45 39.61 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.45 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER 57.25 -111.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 71.0 t -148.43 53.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 122.551 1.167 . . . . 0.0 108.862 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.528 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 7.7 t70 -73.54 -9.12 58.35 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.1 m -92.51 -13.28 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.42 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -107.11 38.95 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 108.76 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.48 -136.23 5.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.93 68.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.958 . . . . 0.0 110.538 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -33.22 19.92 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.852 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -98.83 65.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.324 0.583 . . . . 0.0 109.697 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -101.72 62.07 0.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.17 105.54 1.37 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.4 -163.38 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -1.076 . . . . 0.0 109.552 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -169.93 127.26 0.87 Allowed 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.937 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.0 t -70.51 136.89 49.74 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.41 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.4 m -47.15 -60.91 2.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 0.0 110.781 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.32 -47.04 0.03 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.57 136.82 13.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -71.89 98.41 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.579 -0.954 . . . . 0.0 109.454 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.54 49.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 121.548 -0.72 . . . . 0.0 109.694 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 59.69 59.9 2.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -166.37 103.35 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 p -117.8 169.35 9.68 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.78 0.8 . . . . 0.0 110.311 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -146.13 166.8 15.79 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -74.71 167.69 26.52 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.482 1.455 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -25.93 65.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -71.31 -21.61 62.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.736 . . . . 0.0 109.892 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 8.1 m95 -91.32 20.84 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.071 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HG2' ' CD2' ' A' ' 10' ' ' PHE . 12.1 mmm-85 -97.28 139.22 33.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 21.3 m 86.72 -54.64 0.06 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -93.74 -76.24 0.48 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 24' ' ' TRP . . . 69.96 0.3 26.3 Favored Glycine 0 N--CA 1.487 2.084 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.809 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 1.8 mt-30 52.49 -120.2 1.63 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 25.5 t -149.96 68.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 120.068 1.304 . . . . 0.0 108.885 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.94 26.25 5.94 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.0 m -134.61 178.49 6.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.839 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.4 -78.37 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.9 40.16 1.31 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.48 49.45 76.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -3.13 56.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.671 -0.899 . . . . 0.0 110.449 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.27 -25.71 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.035 -1.04 . . . . 0.0 109.967 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -120.37 63.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.655 -0.653 . . . . 0.0 109.412 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.71 -55.6 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.53 6.35 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.473 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.9 -168.76 2.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -1.043 . . . . 0.0 109.243 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -173.2 121.91 0.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.57 135.86 50.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.411 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 67.9 m -47.16 -67.83 0.24 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.484 -0.76 . . . . 0.0 111.095 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.5 -89.95 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.82 32.09 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -125.97 160.57 29.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.946 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.44 57.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 O-C-N 121.648 -0.657 . . . . 0.0 109.483 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -105.1 -42.02 5.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 109.748 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -142.88 -178.94 6.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.514 -0.741 . . . . 0.0 109.77 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.58 156.02 40.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.655 -0.653 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -150.21 163.85 22.81 Favored Pre-proline 0 N--CA 1.501 2.122 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 30.7 Cg_endo -74.31 162.0 39.3 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 122.003 1.802 . . . . 0.0 111.21 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.24 -28.8 67.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.689 -0.632 . . . . 0.0 109.708 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.0 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 109.622 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.4 m95 -75.36 -5.69 46.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 110.05 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.44 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 28.1 tpt180 -71.98 143.19 49.31 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 17.9 m 85.39 -56.25 0.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.29 -78.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.9 -1.18 40.85 Favored Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.086 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.472 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 5.1 mt-30 52.49 -110.58 0.53 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 12.9 t -154.23 72.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.371 1.081 . . . . 0.0 108.575 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 37.8 t70 -104.56 31.59 4.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.1 m -130.35 172.51 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.677 -0.639 . . . . 0.0 110.322 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.2 -39.25 78.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.598 -0.689 . . . . 0.0 110.572 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -139.24 31.08 2.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 109.711 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.01 41.84 92.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -10.93 59.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -1.009 . . . . 0.0 109.762 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.5 p30 -51.6 -26.01 8.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -97.24 54.56 1.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.66 55.26 2.15 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.431 -0.793 . . . . 0.0 109.63 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.35 127.21 0.69 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -109.76 -168.4 1.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.432 -1.04 . . . . 0.0 109.212 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.473 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -176.37 133.74 0.23 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.628 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -81.06 138.17 35.99 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 59.1 m -48.4 -38.34 19.31 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.333 -0.855 . . . . 0.0 110.386 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.15 -125.2 2.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.04 -105.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -135.67 53.97 1.93 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.959 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.0 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.408 -0.808 . . . . 0.0 109.95 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 179.86 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.413 -0.804 . . . . 0.0 109.711 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 158.7 32.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.661 . . . . 0.0 110.127 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 158.21 44.85 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -150.83 163.83 22.44 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.366 -0.834 . . . . 0.0 108.791 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 31.7 Cg_endo -74.77 164.2 34.12 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.939 1.759 . . . . 0.0 110.715 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -27.94 69.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.601 -0.687 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -66.29 -37.19 84.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.584 -0.698 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.46 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.1 m95 -76.35 -9.99 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.219 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.1 tpt180 -70.73 146.04 50.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 22.6 m 85.88 -58.78 0.07 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.25 -77.85 0.41 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 79.85 -8.84 48.04 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.541 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 3.1 mt-30 55.97 -113.18 0.76 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 37.3 t -151.09 63.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.548 1.166 . . . . 0.0 108.48 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 27.2 t70 -84.56 2.31 41.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.473 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -136.41 24.2 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.0 -1.062 . . . . 0.0 110.112 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.26 63.56 2.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.0 110.426 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.27 24.84 4.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.95 -92.55 0.04 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -145.09 0.84 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.966 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -61.39 -24.01 66.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.472 -1.393 . . . . 0.0 108.94 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.26 40.99 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.85 -64.99 1.07 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.656 -0.653 . . . . 0.0 109.997 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.3 128.36 1.8 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.405 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.43 -167.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -1.085 . . . . 0.0 108.847 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -172.95 125.91 0.45 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.6 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 p -67.24 130.63 43.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 60.1 m -51.05 -46.92 61.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 51.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.92 -166.21 22.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -102.21 122.83 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.56 -0.965 . . . . 0.0 109.728 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p 41.05 34.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -77.38 -66.86 0.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.436 -0.79 . . . . 0.0 108.923 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -171.73 141.75 1.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -99.4 169.51 9.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.483 -0.761 . . . . 0.0 110.369 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.487 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -152.03 169.87 8.84 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 31.4 Cg_endo -75.5 163.85 33.51 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.975 1.783 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -61.78 -28.21 69.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.692 -0.63 . . . . 0.0 109.524 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -65.84 -44.21 86.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.58 -0.7 . . . . 0.0 109.672 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.481 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.7 m95 -70.73 -9.43 57.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.474 -0.766 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.463 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.0 tpt85 -69.25 143.15 54.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.8 t 84.93 -57.47 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -78.69 0.44 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.14 -2.49 35.3 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.034 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.458 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 1.8 mt-30 55.68 -114.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 14.8 t -153.0 71.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 119.631 1.105 . . . . 0.0 108.279 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.84 20.49 10.95 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -156.51 101.77 2.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.11 -0.994 . . . . 0.0 111.43 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.19 -148.31 0.32 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.391 -0.818 . . . . 0.0 109.966 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -54.4 -24.61 20.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.899 -1.126 . . . . 0.0 109.786 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.25 73.36 0.07 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 39' ' ' GLN . 2.4 p -91.8 -13.77 30.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.357 -1.084 . . . . 0.0 109.541 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 1.4 p30 -54.53 -30.04 52.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.607 -1.308 . . . . 0.0 108.61 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.88 49.58 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 36' ' ' SER . 3.2 tt0 -101.03 71.83 1.43 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.84 84.73 1.55 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.528 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.525 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -172.3 4.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.978 . . . . 0.0 108.624 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.462 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -177.6 135.56 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -87.66 123.08 32.13 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 7.1 p -52.45 -35.89 53.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.352 -0.843 . . . . 0.0 110.101 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.09 114.4 0.48 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.89 -171.31 35.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -109.55 79.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.559 -0.965 . . . . 0.0 109.432 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 p -94.93 26.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.512 -0.743 . . . . 0.0 110.154 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.72 31.83 18.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.317 -0.865 . . . . 0.0 109.644 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 112.31 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -109.42 172.41 6.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.562 -0.711 . . . . 0.0 110.392 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -149.14 163.45 25.28 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 31.0 Cg_endo -75.3 163.18 35.15 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.882 1.721 . . . . 0.0 110.794 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.76 -26.67 65.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.568 -0.708 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -67.34 -41.75 84.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.603 . . . . 0.0 109.7 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.48 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.0 m95 -72.56 -11.29 60.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.474 -0.766 . . . . 0.0 110.365 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.451 ' O ' ' CB ' ' A' ' 26' ' ' CYS . 9.0 tpt180 -69.51 139.96 53.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER 85.99 -54.84 0.07 Allowed 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -178.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -102.37 -78.98 0.53 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 59.75 12.52 21.01 Favored Glycine 0 N--CA 1.487 2.066 0 CA-C-O 119.043 -0.865 . . . . 0.0 111.433 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.4 OUTLIER 51.87 -119.24 1.42 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -176.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 40.7 t -149.92 59.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.771 1.272 . . . . 0.0 108.254 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 12.4 t0 -65.14 -16.17 63.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.853 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -117.16 95.99 5.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.68 130.01 41.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.94 24.68 14.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 109.241 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -108.77 -120.63 4.41 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.48 32.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 111.634 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.2 -23.85 16.08 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.603 -1.311 . . . . 0.0 109.544 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.26 60.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.15 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -99.28 -51.7 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.26 47.87 2.64 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.456 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.577 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 -164.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.643 -0.916 . . . . 0.0 108.762 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -174.54 120.72 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.651 -0.655 . . . . 0.0 109.691 178.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -70.68 134.01 47.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.2 m -46.91 -44.82 20.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.562 -0.711 . . . . 0.0 111.222 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.44 43.82 0.02 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.19 -174.25 23.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 58.68 104.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.941 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.66 -25.88 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 0.0 110.294 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -89.72 162.9 15.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.33 -0.856 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 64.23 138.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.749 -0.594 . . . . 0.0 110.251 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.2 -178.03 5.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.269 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' ' 10' ' ' PHE . 41.1 mm -133.58 141.9 41.91 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 28.4 Cg_endo -69.42 157.81 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.451 1.434 . . . . 0.0 111.304 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -53.41 -36.79 61.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.074 0.94 . . . . 0.0 109.621 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -63.39 -41.1 98.75 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.382 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.502 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.4 m95 -78.73 -3.53 44.68 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.065 -1.022 . . . . 0.0 110.342 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HA ' ' CE2' ' A' ' 10' ' ' PHE . 15.9 tpt180 -75.55 151.13 37.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 24.0 m 85.82 -55.39 0.08 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.55 -73.9 0.5 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . 94.31 -26.9 15.21 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.416 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 3.3 mt-30 56.33 -117.24 1.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -176.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 53.6 t -147.63 55.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 122.936 1.351 . . . . 0.0 107.46 174.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.483 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -90.3 15.02 11.23 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.026 178.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.0 m -126.97 12.69 7.25 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 50.96 62.13 2.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.159 -0.963 . . . . 0.0 109.609 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.32 26.48 15.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.42 -111.0 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.55 26.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.671 -0.9 . . . . 0.0 110.971 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -52.98 -30.16 33.34 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.96 -1.088 . . . . 0.0 109.716 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.46 75.26 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -102.67 -40.36 6.65 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.39 -0.819 . . . . 0.0 109.542 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 120.83 0.71 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.577 -0.954 . . . . 0.0 109.42 179.821 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.63 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.67 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.238 . . . . 0.0 109.215 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -172.16 133.49 0.69 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.934 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -76.09 138.71 40.98 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 53.9 m -48.04 -58.45 4.45 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.301 -0.874 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.04 64.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.36 45.28 0.8 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -162.95 75.1 0.4 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.627 -0.925 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.3 -26.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -0.769 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -62.7 -37.52 86.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -107.4 128.21 54.27 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.393 -0.817 . . . . 0.0 109.921 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.6 p -120.49 168.74 11.02 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -146.28 167.73 13.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 32.2 Cg_endo -74.36 163.55 36.04 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.593 1.529 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.29 -27.02 68.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.65 -0.656 . . . . 0.0 109.305 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.31 -31.37 68.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.2 m95 -80.94 2.19 27.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.453 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.426 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 6.2 tpt180 -77.47 138.84 39.47 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.9 t 85.38 -51.43 0.08 Allowed 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.82 -77.74 0.47 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.99 -0.16 47.85 Favored Glycine 0 N--CA 1.488 2.105 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.106 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER 52.55 -113.49 0.76 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 -176.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 16.4 t -152.33 69.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.478 1.132 . . . . 0.0 108.611 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 36.9 t70 -100.99 23.57 10.53 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.863 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 m -132.81 -165.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.93 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.4 -80.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.697 . . . . 0.0 109.759 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -106.54 28.53 7.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.847 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.13 41.41 7.07 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -22.52 64.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.538 -0.977 . . . . 0.0 109.517 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p30 -53.76 -25.69 20.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.079 -1.013 . . . . 0.0 109.598 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.14 48.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.57 108.05 19.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 110.231 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.74 -66.22 1.39 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.87 -179.815 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.82 -168.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -165.93 108.27 0.76 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.78 108.33 1.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.476 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 35.1 t -49.54 -56.85 8.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.749 -0.594 . . . . 0.0 110.826 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.63 174.99 13.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -168.57 43.12 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -173.14 1.0 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.952 . . . . 0.0 109.25 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p 37.86 94.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.189 0.995 . . . . 0.0 111.8 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.01 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.366 0.603 . . . . 0.0 110.928 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.68 112.58 19.46 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.06 169.35 10.48 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.419 -0.801 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -147.78 175.11 2.9 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 32.6 Cg_endo -77.02 152.63 31.77 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 121.561 1.508 . . . . 0.0 110.015 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.34 -19.64 56.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 109.971 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -77.18 -31.77 55.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.463 -0.773 . . . . 0.0 110.332 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 31' ' ' ASP . 5.0 m95 -73.68 -6.05 44.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 110.847 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.467 ' HG2' ' CG ' ' A' ' 10' ' ' PHE . 3.1 mmm-85 -70.11 131.55 44.47 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 12.4 t 87.71 -50.04 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.2 38.03 1.95 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . -53.92 -22.78 20.74 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.428 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 5.4 mt-30 60.96 -122.76 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 55.3 t -145.56 55.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 120.482 1.492 . . . . 0.0 109.908 176.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 29.2 t70 -77.23 -7.94 56.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -102.24 -9.27 20.57 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.243 -0.911 . . . . 0.0 110.683 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 56.56 86.29 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 59.47 25.42 14.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 109.71 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.64 -114.97 1.29 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -161.56 17.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.508 -0.995 . . . . 0.0 112.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.435 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 10.0 p30 -59.24 -21.74 60.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.519 -1.363 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.63 42.83 3.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.428 -0.795 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -91.95 -48.25 6.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 0.0 109.549 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.43 127.73 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.435 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.674 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -168.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.072 -1.252 . . . . 0.0 108.795 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -173.64 120.22 0.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.592 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m -65.66 137.04 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.402 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 29.5 m -49.9 -38.31 35.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.24 50.81 0.41 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.73 -34.22 0.32 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.97 136.98 56.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -1.031 . . . . 0.0 109.741 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.6 -39.1 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.688 -0.633 . . . . 0.0 109.598 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.08 98.06 3.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.677 . . . . 0.0 109.797 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -175.48 144.18 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 172.42 12.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.835 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -151.61 166.77 14.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.507 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.9 Cg_endo -73.84 162.66 38.87 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.582 1.522 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.82 71.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.984 0.897 . . . . 0.0 109.782 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.18 -39.35 92.39 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.479 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.507 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.2 m95 -76.35 -6.84 53.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.18 -0.95 . . . . 0.0 110.968 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 1.5 tpt180 -70.95 141.36 51.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 2.0 t 85.35 -51.13 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.51 -79.37 0.45 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 74.87 -6.85 24.19 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER 53.09 -112.37 0.69 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 38.4 t -151.04 66.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.431 1.11 . . . . 0.0 108.423 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.444 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 25.5 t0 -97.58 24.88 6.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.7 m -136.6 13.25 3.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.687 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 39.23 78.62 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 O-C-N 121.771 -0.581 . . . . 0.0 111.257 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 23.04 10.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.736 . . . . 0.0 109.251 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.27 -104.12 0.1 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.33 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -1.028 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 6.5 p30 -55.17 -23.14 20.15 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.755 -1.216 . . . . 0.0 110.012 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -127.25 46.26 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -114.27 -42.7 3.3 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.587 -0.696 . . . . 0.0 109.94 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.87 -40.97 34.77 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 26' ' ' CYS . 34.6 t . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.17 43.32 14.2 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.416 -0.803 . . . . 0.0 109.514 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.32 152.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.967 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 p -123.84 156.27 36.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.603 -0.686 . . . . 0.0 109.324 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.42 22.52 15.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.541 -0.724 . . . . 0.0 109.975 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 58.1 -170.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -102.91 140.54 37.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.608 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.11 10.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.88 -165.41 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.451 -1.029 . . . . 0.0 109.293 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' CE1' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -172.99 109.14 0.18 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.6 p -68.54 120.28 14.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 28.5 t -49.28 -65.4 0.57 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 110.833 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.36 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.4 25.89 72.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.33 72.96 0.49 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.387 -1.067 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.9 p -57.35 -23.6 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.052 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.1 p30 179.68 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.354 -0.841 . . . . 0.0 109.83 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -155.45 -175.63 5.53 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.61 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.23 175.35 6.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.669 -0.644 . . . . 0.0 109.322 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.477 ' HB ' ' CD2' ' A' ' 10' ' ' PHE . 37.8 mm -130.28 139.8 36.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.8 Cg_endo -71.06 159.1 53.39 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.414 1.409 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.35 -26.64 63.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.553 -0.717 . . . . 0.0 109.073 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.05 -39.34 83.03 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.707 -0.621 . . . . 0.0 109.484 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.528 ' CE3' ' HB2' ' A' ' 31' ' ' ASP . 11.9 m95 -81.37 -3.99 54.39 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 24.9 tpt180 -76.35 148.92 37.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.388 -1.445 . . . . 0.0 107.504 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 5.1 t 86.27 -56.32 0.06 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.47 -76.17 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.89 -18.45 39.61 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.45 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER 57.25 -111.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.45 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 71.0 t -148.43 53.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 122.551 1.167 . . . . 0.0 108.862 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.528 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 7.7 t70 -73.54 -9.12 58.35 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.1 m -92.51 -13.28 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.42 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -107.11 38.95 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 108.76 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.48 -136.23 5.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.93 68.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.958 . . . . 0.0 110.538 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -33.22 19.92 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.852 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -98.83 65.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.324 0.583 . . . . 0.0 109.697 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -101.72 62.07 0.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.17 105.54 1.37 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.7 m -129.23 102.06 6.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.536 -0.727 . . . . 0.0 109.564 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.79 101.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.563 -0.71 . . . . 0.0 109.548 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -144.26 167.28 22.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.661 -0.649 . . . . 0.0 109.267 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 4' ' ' THR . 21.1 m 84.05 -51.36 0.13 Allowed 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 122.663 0.385 . . . . 0.0 110.685 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 67.11 -166.14 0.21 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.244 -0.91 . . . . 0.0 108.929 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 p -77.22 152.94 34.51 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 0.0 109.894 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.75 37.21 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.4 -163.38 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -1.076 . . . . 0.0 109.552 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.502 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.4 OUTLIER -169.93 127.26 0.87 Allowed 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.937 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.0 t -70.51 136.89 49.74 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.41 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.4 m -47.15 -60.91 2.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 0.0 110.781 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.32 -47.04 0.03 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.57 136.82 13.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -71.89 98.41 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.579 -0.954 . . . . 0.0 109.454 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.54 49.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 121.548 -0.72 . . . . 0.0 109.694 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 59.69 59.9 2.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -166.37 103.35 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 p -117.8 169.35 9.68 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.78 0.8 . . . . 0.0 110.311 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.502 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -146.13 166.8 15.79 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 32.5 Cg_endo -74.71 167.69 26.52 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.482 1.455 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -25.93 65.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -71.31 -21.61 62.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.736 . . . . 0.0 109.892 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 8.1 m95 -91.32 20.84 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.071 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.442 ' HG2' ' CD2' ' A' ' 10' ' ' PHE . 12.1 mmm-85 -97.28 139.22 33.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 21.3 m 86.72 -54.64 0.06 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -93.74 -76.24 0.48 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 24' ' ' TRP . . . 69.96 0.3 26.3 Favored Glycine 0 N--CA 1.487 2.084 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.809 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.455 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 1.8 mt-30 52.49 -120.2 1.63 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 25.5 t -149.96 68.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 120.068 1.304 . . . . 0.0 108.885 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.94 26.25 5.94 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.0 m -134.61 178.49 6.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.839 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.4 -78.37 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.9 40.16 1.31 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.48 49.45 76.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -3.13 56.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.671 -0.899 . . . . 0.0 110.449 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.27 -25.71 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.035 -1.04 . . . . 0.0 109.967 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -120.37 63.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.655 -0.653 . . . . 0.0 109.412 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.71 -55.6 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.53 6.35 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.473 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m 58.67 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.42 153.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.957 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -140.18 142.99 35.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.691 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m 59.22 80.45 0.19 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.792 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 pttm -137.42 63.78 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.796 . . . . 0.0 109.663 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.85 -73.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.555 -0.716 . . . . 0.0 109.218 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.86 24.7 2.27 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.9 -168.76 2.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -1.043 . . . . 0.0 109.243 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.472 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -173.2 121.91 0.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.57 135.86 50.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.411 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 67.9 m -47.16 -67.83 0.24 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.484 -0.76 . . . . 0.0 111.095 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.5 -89.95 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.82 32.09 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -125.97 160.57 29.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.946 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.44 57.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 O-C-N 121.648 -0.657 . . . . 0.0 109.483 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -105.1 -42.02 5.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 109.748 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -142.88 -178.94 6.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.514 -0.741 . . . . 0.0 109.77 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.58 156.02 40.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.655 -0.653 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.472 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -150.21 163.85 22.81 Favored Pre-proline 0 N--CA 1.501 2.122 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 30.7 Cg_endo -74.31 162.0 39.3 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 122.003 1.802 . . . . 0.0 111.21 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.24 -28.8 67.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.689 -0.632 . . . . 0.0 109.708 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.0 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 109.622 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.4 m95 -75.36 -5.69 46.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 110.05 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.44 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 28.1 tpt180 -71.98 143.19 49.31 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 17.9 m 85.39 -56.25 0.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.29 -78.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.9 -1.18 40.85 Favored Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.086 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.472 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 5.1 mt-30 52.49 -110.58 0.53 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 12.9 t -154.23 72.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.371 1.081 . . . . 0.0 108.575 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 37.8 t70 -104.56 31.59 4.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.1 m -130.35 172.51 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.677 -0.639 . . . . 0.0 110.322 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.2 -39.25 78.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.598 -0.689 . . . . 0.0 110.572 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -139.24 31.08 2.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 109.711 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.01 41.84 92.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -10.93 59.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -1.009 . . . . 0.0 109.762 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.5 p30 -51.6 -26.01 8.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -97.24 54.56 1.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.66 55.26 2.15 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.431 -0.793 . . . . 0.0 109.63 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.35 127.21 0.69 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -167.8 138.09 2.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 109.79 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.45 -24.59 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 110.073 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.1 -90.55 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 0.0 110.733 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.48 34.28 24.4 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.968 -1.082 . . . . 0.0 109.28 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.02 -161.97 0.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 p -118.63 162.69 17.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.387 -0.82 . . . . 0.0 109.97 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.29 25.15 68.11 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -109.76 -168.4 1.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.432 -1.04 . . . . 0.0 109.212 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.473 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -176.37 133.74 0.23 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.628 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -81.06 138.17 35.99 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.437 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 59.1 m -48.4 -38.34 19.31 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.333 -0.855 . . . . 0.0 110.386 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.15 -125.2 2.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.04 -105.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -135.67 53.97 1.93 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.959 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.0 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.408 -0.808 . . . . 0.0 109.95 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 179.86 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.413 -0.804 . . . . 0.0 109.711 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 158.7 32.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.661 . . . . 0.0 110.127 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 158.21 44.85 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -150.83 163.83 22.44 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.366 -0.834 . . . . 0.0 108.791 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 31.7 Cg_endo -74.77 164.2 34.12 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.939 1.759 . . . . 0.0 110.715 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -27.94 69.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.601 -0.687 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -66.29 -37.19 84.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.584 -0.698 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.46 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.1 m95 -76.35 -9.99 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.219 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.1 tpt180 -70.73 146.04 50.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 22.6 m 85.88 -58.78 0.07 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.25 -77.85 0.41 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 79.85 -8.84 48.04 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.541 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 3.1 mt-30 55.97 -113.18 0.76 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 37.3 t -151.09 63.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.548 1.166 . . . . 0.0 108.48 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 27.2 t70 -84.56 2.31 41.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.473 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -136.41 24.2 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.0 -1.062 . . . . 0.0 110.112 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.26 63.56 2.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.0 110.426 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.27 24.84 4.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.95 -92.55 0.04 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -145.09 0.84 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.966 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -61.39 -24.01 66.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.472 -1.393 . . . . 0.0 108.94 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.26 40.99 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.85 -64.99 1.07 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.656 -0.653 . . . . 0.0 109.997 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.3 128.36 1.8 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.405 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.84 79.39 1.32 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.549 -0.719 . . . . 0.0 109.344 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.8 p 40.5 35.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.019 0.438 . . . . 0.0 112.061 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -143.45 133.79 24.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.491 ' HB2' ' CB ' ' A' ' 9' ' ' ASP . 26.3 p 35.68 69.74 0.17 Allowed 'General case' 0 N--CA 1.511 2.616 0 CA-C-O 121.247 0.546 . . . . 0.0 112.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -95.68 53.1 1.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m -146.53 77.24 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 109.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.23 18.5 60.63 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.491 ' CB ' ' HB2' ' A' ' 5' ' ' CYS . 8.7 m-20 -105.43 -167.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -1.085 . . . . 0.0 108.847 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -172.95 125.91 0.45 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.6 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 p -67.24 130.63 43.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 60.1 m -51.05 -46.92 61.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 51.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.92 -166.21 22.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 -102.21 122.83 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.56 -0.965 . . . . 0.0 109.728 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 p 41.05 34.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -77.38 -66.86 0.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.436 -0.79 . . . . 0.0 108.923 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -171.73 141.75 1.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -99.4 169.51 9.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.483 -0.761 . . . . 0.0 110.369 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.487 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -152.03 169.87 8.84 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 31.4 Cg_endo -75.5 163.85 33.51 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.975 1.783 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -61.78 -28.21 69.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.692 -0.63 . . . . 0.0 109.524 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -65.84 -44.21 86.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.58 -0.7 . . . . 0.0 109.672 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.481 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.7 m95 -70.73 -9.43 57.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.474 -0.766 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.463 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.0 tpt85 -69.25 143.15 54.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.8 t 84.93 -57.47 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -78.69 0.44 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.14 -2.49 35.3 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.034 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.458 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 1.8 mt-30 55.68 -114.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 14.8 t -153.0 71.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 119.631 1.105 . . . . 0.0 108.279 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -96.84 20.49 10.95 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -156.51 101.77 2.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.11 -0.994 . . . . 0.0 111.43 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.19 -148.31 0.32 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.391 -0.818 . . . . 0.0 109.966 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -54.4 -24.61 20.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.899 -1.126 . . . . 0.0 109.786 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.25 73.36 0.07 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 39' ' ' GLN . 2.4 p -91.8 -13.77 30.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.357 -1.084 . . . . 0.0 109.541 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 1.4 p30 -54.53 -30.04 52.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.607 -1.308 . . . . 0.0 108.61 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.88 49.58 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 36' ' ' SER . 3.2 tt0 -101.03 71.83 1.43 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.84 84.73 1.55 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.528 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.426 ' N ' ' CD1' ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.128 0.489 . . . . 0.0 109.901 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 p -118.54 -43.6 2.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.279 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.04 -25.55 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.623 -0.673 . . . . 0.0 109.973 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -170.94 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.83 22.84 12.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.667 . . . . 0.0 110.134 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.89 -161.75 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.231 -0.918 . . . . 0.0 109.67 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.7 m -100.66 166.99 10.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.11 40.85 99.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -172.3 4.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.978 . . . . 0.0 108.624 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.462 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -177.6 135.56 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -87.66 123.08 32.13 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 7.1 p -52.45 -35.89 53.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.352 -0.843 . . . . 0.0 110.101 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.09 114.4 0.48 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.89 -171.31 35.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -109.55 79.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.559 -0.965 . . . . 0.0 109.432 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.9 p -94.93 26.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.512 -0.743 . . . . 0.0 110.154 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.72 31.83 18.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.317 -0.865 . . . . 0.0 109.644 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 112.31 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -109.42 172.41 6.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.562 -0.711 . . . . 0.0 110.392 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.462 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -149.14 163.45 25.28 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 31.0 Cg_endo -75.3 163.18 35.15 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.882 1.721 . . . . 0.0 110.794 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.76 -26.67 65.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.568 -0.708 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -67.34 -41.75 84.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.603 . . . . 0.0 109.7 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.48 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.0 m95 -72.56 -11.29 60.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.474 -0.766 . . . . 0.0 110.365 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' O ' ' CB ' ' A' ' 26' ' ' CYS . 9.0 tpt180 -69.51 139.96 53.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER 85.99 -54.84 0.07 Allowed 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -178.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -102.37 -78.98 0.53 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 59.75 12.52 21.01 Favored Glycine 0 N--CA 1.487 2.066 0 CA-C-O 119.043 -0.865 . . . . 0.0 111.433 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.4 OUTLIER 51.87 -119.24 1.42 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -176.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 40.7 t -149.92 59.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.771 1.272 . . . . 0.0 108.254 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 12.4 t0 -65.14 -16.17 63.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.853 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -117.16 95.99 5.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.68 130.01 41.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.94 24.68 14.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 109.241 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -108.77 -120.63 4.41 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.48 32.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 111.634 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.2 -23.85 16.08 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.603 -1.311 . . . . 0.0 109.544 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.26 60.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.15 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -99.28 -51.7 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.26 47.87 2.64 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.456 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 t -157.67 30.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.77 -14.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.626 -0.671 . . . . 0.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.58 -78.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 0.0 110.102 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.12 59.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 109.758 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt 57.64 -174.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -102.38 44.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.48 -51.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 -164.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.643 -0.916 . . . . 0.0 108.762 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -174.54 120.72 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.651 -0.655 . . . . 0.0 109.691 178.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -70.68 134.01 47.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.2 m -46.91 -44.82 20.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.562 -0.711 . . . . 0.0 111.222 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.44 43.82 0.02 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.19 -174.25 23.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 58.68 104.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.941 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.66 -25.88 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 0.0 110.294 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -89.72 162.9 15.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.33 -0.856 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 64.23 138.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.749 -0.594 . . . . 0.0 110.251 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.2 -178.03 5.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.269 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.481 ' HB ' ' CD2' ' A' ' 10' ' ' PHE . 41.1 mm -133.58 141.9 41.91 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 28.4 Cg_endo -69.42 157.81 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.451 1.434 . . . . 0.0 111.304 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -53.41 -36.79 61.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.074 0.94 . . . . 0.0 109.621 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -63.39 -41.1 98.75 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.382 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.502 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.4 m95 -78.73 -3.53 44.68 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.065 -1.022 . . . . 0.0 110.342 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HA ' ' CE2' ' A' ' 10' ' ' PHE . 15.9 tpt180 -75.55 151.13 37.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 24.0 m 85.82 -55.39 0.08 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.55 -73.9 0.5 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . 94.31 -26.9 15.21 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.416 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 3.3 mt-30 56.33 -117.24 1.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -176.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 53.6 t -147.63 55.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 122.936 1.351 . . . . 0.0 107.46 174.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.483 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -90.3 15.02 11.23 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.026 178.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.0 m -126.97 12.69 7.25 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 50.96 62.13 2.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.159 -0.963 . . . . 0.0 109.609 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.32 26.48 15.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.42 -111.0 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.55 26.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.671 -0.9 . . . . 0.0 110.971 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -52.98 -30.16 33.34 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.96 -1.088 . . . . 0.0 109.716 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.46 75.26 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -102.67 -40.36 6.65 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.39 -0.819 . . . . 0.0 109.542 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 120.83 0.71 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.0 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.577 -0.954 . . . . 0.0 109.42 179.821 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p 55.69 178.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.661 -0.65 . . . . 0.0 110.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -70.26 164.97 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.704 -0.622 . . . . 0.0 110.251 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.6 p 57.02 -167.26 0.12 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.421 0.629 . . . . 0.0 110.401 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.64 24.31 4.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.665 -0.647 . . . . 0.0 110.147 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.06 177.03 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.863 . . . . 0.0 109.732 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -89.83 165.07 14.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.599 -0.688 . . . . 0.0 110.113 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.03 83.56 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.67 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.238 . . . . 0.0 109.215 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.49 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.2 OUTLIER -172.16 133.49 0.69 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.934 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -76.09 138.71 40.98 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.405 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 53.9 m -48.04 -58.45 4.45 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.301 -0.874 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.04 64.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.36 45.28 0.8 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -162.95 75.1 0.4 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.627 -0.925 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.3 -26.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -0.769 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -62.7 -37.52 86.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -107.4 128.21 54.27 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.393 -0.817 . . . . 0.0 109.921 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.6 p -120.49 168.74 11.02 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.49 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -146.28 167.73 13.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 32.2 Cg_endo -74.36 163.55 36.04 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.593 1.529 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.29 -27.02 68.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.65 -0.656 . . . . 0.0 109.305 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.31 -31.37 68.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.2 m95 -80.94 2.19 27.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.453 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.426 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 6.2 tpt180 -77.47 138.84 39.47 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.9 t 85.38 -51.43 0.08 Allowed 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.82 -77.74 0.47 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.99 -0.16 47.85 Favored Glycine 0 N--CA 1.488 2.105 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.106 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.5 OUTLIER 52.55 -113.49 0.76 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 -176.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 16.4 t -152.33 69.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.478 1.132 . . . . 0.0 108.611 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 36.9 t70 -100.99 23.57 10.53 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.863 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 m -132.81 -165.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.93 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.4 -80.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.697 . . . . 0.0 109.759 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -106.54 28.53 7.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.847 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.13 41.41 7.07 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -22.52 64.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.538 -0.977 . . . . 0.0 109.517 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p30 -53.76 -25.69 20.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.079 -1.013 . . . . 0.0 109.598 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.14 48.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.57 108.05 19.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 110.231 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.74 -66.22 1.39 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.87 -179.815 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -143.67 24.94 1.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 109.864 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.2 p -62.58 125.68 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 109.471 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.23 -175.69 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 86.0 m 57.93 82.53 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.808 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.78 94.87 3.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.597 -0.689 . . . . 0.0 109.84 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.47 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.758 . . . . 0.0 109.665 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.42 26.01 14.7 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.82 -168.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.496 ' CE2' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -165.93 108.27 0.76 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.78 108.33 1.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.476 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 35.1 t -49.54 -56.85 8.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.749 -0.594 . . . . 0.0 110.826 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.63 174.99 13.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -168.57 43.12 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -173.14 1.0 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.952 . . . . 0.0 109.25 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p 37.86 94.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.189 0.995 . . . . 0.0 111.8 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.01 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.366 0.603 . . . . 0.0 110.928 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.68 112.58 19.46 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.06 169.35 10.48 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.419 -0.801 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.496 ' CD1' ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -147.78 175.11 2.9 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 32.6 Cg_endo -77.02 152.63 31.77 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 121.561 1.508 . . . . 0.0 110.015 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.34 -19.64 56.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 109.971 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -77.18 -31.77 55.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.463 -0.773 . . . . 0.0 110.332 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.505 ' CZ3' ' HB2' ' A' ' 31' ' ' ASP . 5.0 m95 -73.68 -6.05 44.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 110.847 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.467 ' HG2' ' CG ' ' A' ' 10' ' ' PHE . 3.1 mmm-85 -70.11 131.55 44.47 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 12.4 t 87.71 -50.04 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.2 38.03 1.95 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . -53.92 -22.78 20.74 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.428 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 5.4 mt-30 60.96 -122.76 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 55.3 t -145.56 55.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 120.482 1.492 . . . . 0.0 109.908 176.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 29.2 t70 -77.23 -7.94 56.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 58.6 m -102.24 -9.27 20.57 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.243 -0.911 . . . . 0.0 110.683 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 56.56 86.29 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 59.47 25.42 14.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 109.71 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.64 -114.97 1.29 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -161.56 17.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.508 -0.995 . . . . 0.0 112.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.435 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 10.0 p30 -59.24 -21.74 60.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.519 -1.363 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.63 42.83 3.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.428 -0.795 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -91.95 -48.25 6.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 0.0 109.549 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.43 127.73 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.435 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -64.76 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.6 -0.687 . . . . 0.0 109.307 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.3 121.82 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.534 -0.729 . . . . 0.0 109.862 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.23 -50.33 1.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.496 -0.753 . . . . 0.0 109.326 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.32 -73.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.05 -45.94 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 t -176.03 -66.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 110.498 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.22 -3.96 50.73 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.156 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -168.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.072 -1.252 . . . . 0.0 108.795 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -173.64 120.22 0.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.592 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m -65.66 137.04 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.402 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 29.5 m -49.9 -38.31 35.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.24 50.81 0.41 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.73 -34.22 0.32 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.97 136.98 56.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -1.031 . . . . 0.0 109.741 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.6 -39.1 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.688 -0.633 . . . . 0.0 109.598 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.08 98.06 3.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.677 . . . . 0.0 109.797 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -175.48 144.18 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 172.42 12.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.835 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.478 ' CD1' ' CZ ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -151.61 166.77 14.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.507 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.9 Cg_endo -73.84 162.66 38.87 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.582 1.522 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.82 71.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.984 0.897 . . . . 0.0 109.782 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.18 -39.35 92.39 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.479 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.507 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.2 m95 -76.35 -6.84 53.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.18 -0.95 . . . . 0.0 110.968 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.448 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 1.5 tpt180 -70.95 141.36 51.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 2.0 t 85.35 -51.13 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.51 -79.37 0.45 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 74.87 -6.85 24.19 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.459 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 0.2 OUTLIER 53.09 -112.37 0.69 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.305 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.459 ' CG2' ' O ' ' A' ' 29' ' ' GLN . 38.4 t -151.04 66.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.431 1.11 . . . . 0.0 108.423 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.444 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 25.5 t0 -97.58 24.88 6.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 68.7 m -136.6 13.25 3.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.687 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 39.23 78.62 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 O-C-N 121.771 -0.581 . . . . 0.0 111.257 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 23.04 10.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.736 . . . . 0.0 109.251 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.27 -104.12 0.1 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.33 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -1.028 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.407 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 6.5 p30 -55.17 -23.14 20.15 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.755 -1.216 . . . . 0.0 110.012 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -127.25 46.26 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -114.27 -42.7 3.3 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.587 -0.696 . . . . 0.0 109.94 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.87 -40.97 34.77 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 26' ' ' CYS . 34.6 t . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.506 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.88 -165.41 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.451 -1.029 . . . . 0.0 109.293 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -172.99 109.14 0.18 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.6 p -68.54 120.28 14.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 28.5 t -49.28 -65.4 0.57 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 110.833 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.36 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.4 25.89 72.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.33 72.96 0.49 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.387 -1.067 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 17' ' ' ASN . 9.9 p -57.35 -23.6 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' CG ' HG13 ' A' ' 16' ' ' VAL . 3.1 p30 179.68 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.354 -0.841 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -155.45 -175.63 5.53 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.61 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.23 175.35 6.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.669 -0.644 . . . . 0.0 109.322 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 24' ' ' TRP . 37.8 mm -130.28 139.8 36.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.8 Cg_endo -71.06 159.1 53.39 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.414 1.409 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.35 -26.64 63.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.553 -0.717 . . . . 0.0 109.073 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.05 -39.34 83.03 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.707 -0.621 . . . . 0.0 109.484 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.549 ' CE3' ' HB2' ' A' ' 31' ' ' ASP . 11.9 m95 -81.37 -3.99 54.39 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.491 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 24.9 tpt180 -76.35 148.92 37.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.388 -1.445 . . . . 0.0 107.504 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 5.1 t 86.27 -56.32 0.06 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.47 -76.17 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.89 -18.45 39.61 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.5 OUTLIER 57.25 -111.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 30' ' ' VAL . 71.0 t -148.43 53.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 122.551 1.167 . . . . 0.0 108.862 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 7.7 t70 -73.54 -9.12 58.35 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HA ' HG11 ' A' ' 16' ' ' VAL . 61.1 m -92.51 -13.28 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.42 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -107.11 38.95 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 108.76 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.48 -136.23 5.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.93 68.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.958 . . . . 0.0 110.538 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -33.22 19.92 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.852 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -98.83 65.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.324 0.583 . . . . 0.0 109.697 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -101.72 62.07 0.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.17 105.54 1.37 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.4 -163.38 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -1.076 . . . . 0.0 109.552 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -169.93 127.26 0.87 Allowed 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.937 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.0 t -70.51 136.89 49.74 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 20' ' ' ILE . 82.4 m -47.15 -60.91 2.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 0.0 110.781 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.32 -47.04 0.03 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.57 136.82 13.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -71.89 98.41 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.579 -0.954 . . . . 0.0 109.454 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 16' ' ' VAL . 47.5 t -139.54 49.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 121.548 -0.72 . . . . 0.0 109.694 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 59.69 59.9 2.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -166.37 103.35 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 p -117.8 169.35 9.68 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.78 0.8 . . . . 0.0 110.311 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.13 166.8 15.79 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.5 Cg_endo -74.71 167.69 26.52 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.482 1.455 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -25.93 65.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -71.31 -21.61 62.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.736 . . . . 0.0 109.892 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.611 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 8.1 m95 -91.32 20.84 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.071 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 10' ' ' PHE . 12.1 mmm-85 -97.28 139.22 33.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 21.3 m 86.72 -54.64 0.06 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -93.74 -76.24 0.48 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 24' ' ' TRP . . . 69.96 0.3 26.3 Favored Glycine 0 N--CA 1.487 2.084 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.809 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 52.49 -120.2 1.63 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 29' ' ' GLN . 25.5 t -149.96 68.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 120.068 1.304 . . . . 0.0 108.885 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.94 26.25 5.94 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.0 m -134.61 178.49 6.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.839 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.4 -78.37 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.9 40.16 1.31 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.48 49.45 76.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -3.13 56.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.671 -0.899 . . . . 0.0 110.449 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.27 -25.71 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.035 -1.04 . . . . 0.0 109.967 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -120.37 63.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.655 -0.653 . . . . 0.0 109.412 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 -55.6 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.53 6.35 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.473 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.9 -168.76 2.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -1.043 . . . . 0.0 109.243 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -173.2 121.91 0.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.57 135.86 50.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 20' ' ' ILE . 67.9 m -47.16 -67.83 0.24 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.484 -0.76 . . . . 0.0 111.095 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.5 -89.95 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.82 32.09 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -125.97 160.57 29.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.946 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 16' ' ' VAL . 7.2 p -89.44 57.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 O-C-N 121.648 -0.657 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -105.1 -42.02 5.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 109.748 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -142.88 -178.94 6.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.514 -0.741 . . . . 0.0 109.77 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.58 156.02 40.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.655 -0.653 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -150.21 163.85 22.81 Favored Pre-proline 0 N--CA 1.501 2.122 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 20' ' ' ILE . 30.7 Cg_endo -74.31 162.0 39.3 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 122.003 1.802 . . . . 0.0 111.21 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.24 -28.8 67.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.689 -0.632 . . . . 0.0 109.708 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.0 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 109.622 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.4 m95 -75.36 -5.69 46.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 110.05 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 28.1 tpt180 -71.98 143.19 49.31 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 17.9 m 85.39 -56.25 0.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.29 -78.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.9 -1.18 40.85 Favored Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.086 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 30' ' ' VAL . 5.1 mt-30 52.49 -110.58 0.53 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 29' ' ' GLN . 12.9 t -154.23 72.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.371 1.081 . . . . 0.0 108.575 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 37.8 t70 -104.56 31.59 4.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.1 m -130.35 172.51 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.677 -0.639 . . . . 0.0 110.322 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.2 -39.25 78.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.598 -0.689 . . . . 0.0 110.572 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -139.24 31.08 2.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 109.711 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.01 41.84 92.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -10.93 59.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -1.009 . . . . 0.0 109.762 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.5 p30 -51.6 -26.01 8.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -97.24 54.56 1.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.66 55.26 2.15 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.431 -0.793 . . . . 0.0 109.63 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.35 127.21 0.69 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -109.76 -168.4 1.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.432 -1.04 . . . . 0.0 109.212 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -176.37 133.74 0.23 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.628 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -81.06 138.17 35.99 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.711 ' SG ' HD11 ' A' ' 20' ' ' ILE . 59.1 m -48.4 -38.34 19.31 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.333 -0.855 . . . . 0.0 110.386 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.15 -125.2 2.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.04 -105.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -135.67 53.97 1.93 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.959 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.0 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.408 -0.808 . . . . 0.0 109.95 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 179.86 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.413 -0.804 . . . . 0.0 109.711 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 158.7 32.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.661 . . . . 0.0 110.127 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 158.21 44.85 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.711 HD11 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -150.83 163.83 22.44 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.366 -0.834 . . . . 0.0 108.791 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.7 Cg_endo -74.77 164.2 34.12 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.939 1.759 . . . . 0.0 110.715 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -27.94 69.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.601 -0.687 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -66.29 -37.19 84.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.584 -0.698 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.1 m95 -76.35 -9.99 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.219 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.1 tpt180 -70.73 146.04 50.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 22.6 m 85.88 -58.78 0.07 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.25 -77.85 0.41 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 79.85 -8.84 48.04 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.541 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.7 mt-30 55.97 -113.18 0.76 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 30' ' ' VAL . 37.3 t -151.09 63.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.548 1.166 . . . . 0.0 108.48 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 27.2 t70 -84.56 2.31 41.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.473 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -136.41 24.2 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.0 -1.062 . . . . 0.0 110.112 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.26 63.56 2.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.0 110.426 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.27 24.84 4.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.95 -92.55 0.04 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -145.09 0.84 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.966 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -61.39 -24.01 66.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.472 -1.393 . . . . 0.0 108.94 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.26 40.99 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.85 -64.99 1.07 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.656 -0.653 . . . . 0.0 109.997 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.3 128.36 1.8 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.405 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.43 -167.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -1.085 . . . . 0.0 108.847 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -172.95 125.91 0.45 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.6 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 p -67.24 130.63 43.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.601 ' SG ' HD11 ' A' ' 20' ' ' ILE . 60.1 m -51.05 -46.92 61.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 51.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.92 -166.21 22.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.459 ' O ' HG12 ' A' ' 16' ' ' VAL . 9.7 mmt180 -102.21 122.83 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.56 -0.965 . . . . 0.0 109.728 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.576 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.6 p 41.05 34.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -77.38 -66.86 0.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.436 -0.79 . . . . 0.0 108.923 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -171.73 141.75 1.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -99.4 169.51 9.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.483 -0.761 . . . . 0.0 110.369 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.659 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -152.03 169.87 8.84 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.4 Cg_endo -75.5 163.85 33.51 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.975 1.783 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -61.78 -28.21 69.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.692 -0.63 . . . . 0.0 109.524 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -65.84 -44.21 86.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.58 -0.7 . . . . 0.0 109.672 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.519 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.7 m95 -70.73 -9.43 57.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.474 -0.766 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.487 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.0 tpt85 -69.25 143.15 54.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.8 t 84.93 -57.47 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -78.69 0.44 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.14 -2.49 35.3 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.034 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.678 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 55.68 -114.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 29' ' ' GLN . 14.8 t -153.0 71.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 119.631 1.105 . . . . 0.0 108.279 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 23.4 t0 -96.84 20.49 10.95 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -156.51 101.77 2.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.11 -0.994 . . . . 0.0 111.43 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.19 -148.31 0.32 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.391 -0.818 . . . . 0.0 109.966 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -54.4 -24.61 20.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.899 -1.126 . . . . 0.0 109.786 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.25 73.36 0.07 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 39' ' ' GLN . 2.4 p -91.8 -13.77 30.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.357 -1.084 . . . . 0.0 109.541 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 1.4 p30 -54.53 -30.04 52.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.607 -1.308 . . . . 0.0 108.61 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.88 49.58 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 36' ' ' SER . 3.2 tt0 -101.03 71.83 1.43 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.84 84.73 1.55 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.528 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.525 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -172.3 4.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.978 . . . . 0.0 108.624 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -177.6 135.56 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -87.66 123.08 32.13 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.744 ' HB3' HD11 ' A' ' 20' ' ' ILE . 7.1 p -52.45 -35.89 53.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.352 -0.843 . . . . 0.0 110.101 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.09 114.4 0.48 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.89 -171.31 35.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -109.55 79.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.559 -0.965 . . . . 0.0 109.432 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 16' ' ' VAL . 13.9 p -94.93 26.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.512 -0.743 . . . . 0.0 110.154 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.72 31.83 18.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.317 -0.865 . . . . 0.0 109.644 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HB2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -140.09 112.31 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -109.42 172.41 6.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.562 -0.711 . . . . 0.0 110.392 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -149.14 163.45 25.28 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.0 Cg_endo -75.3 163.18 35.15 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.882 1.721 . . . . 0.0 110.794 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.76 -26.67 65.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.568 -0.708 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -67.34 -41.75 84.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.603 . . . . 0.0 109.7 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.0 m95 -72.56 -11.29 60.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.474 -0.766 . . . . 0.0 110.365 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 9.0 tpt180 -69.51 139.96 53.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER 85.99 -54.84 0.07 Allowed 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -178.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -102.37 -78.98 0.53 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 59.75 12.52 21.01 Favored Glycine 0 N--CA 1.487 2.066 0 CA-C-O 119.043 -0.865 . . . . 0.0 111.433 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER 51.87 -119.24 1.42 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -176.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 30' ' ' VAL . 40.7 t -149.92 59.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.771 1.272 . . . . 0.0 108.254 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 12.4 t0 -65.14 -16.17 63.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.853 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 1.4 m -117.16 95.99 5.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.68 130.01 41.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.94 24.68 14.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 109.241 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -108.77 -120.63 4.41 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.48 32.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 111.634 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.2 -23.85 16.08 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.603 -1.311 . . . . 0.0 109.544 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.26 60.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.15 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -99.28 -51.7 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.26 47.87 2.64 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.456 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.577 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 -164.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.643 -0.916 . . . . 0.0 108.762 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.508 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -174.54 120.72 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.651 -0.655 . . . . 0.0 109.691 178.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -70.68 134.01 47.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.2 m -46.91 -44.82 20.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.562 -0.711 . . . . 0.0 111.222 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.44 43.82 0.02 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.19 -174.25 23.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 58.68 104.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.941 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.66 -25.88 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 0.0 110.294 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -89.72 162.9 15.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.33 -0.856 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 64.23 138.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.749 -0.594 . . . . 0.0 110.251 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.2 -178.03 5.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.269 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 24' ' ' TRP . 41.1 mm -133.58 141.9 41.91 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 28.4 Cg_endo -69.42 157.81 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.451 1.434 . . . . 0.0 111.304 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -53.41 -36.79 61.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.074 0.94 . . . . 0.0 109.621 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -63.39 -41.1 98.75 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.382 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.4 m95 -78.73 -3.53 44.68 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.065 -1.022 . . . . 0.0 110.342 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' CE2' ' A' ' 10' ' ' PHE . 15.9 tpt180 -75.55 151.13 37.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 24.0 m 85.82 -55.39 0.08 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.55 -73.9 0.5 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . 94.31 -26.9 15.21 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 30' ' ' VAL . 8.6 mt-30 56.33 -117.24 1.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 53.6 t -147.63 55.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 122.936 1.351 . . . . 0.0 107.46 174.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -90.3 15.02 11.23 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.026 178.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.0 m -126.97 12.69 7.25 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 50.96 62.13 2.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.159 -0.963 . . . . 0.0 109.609 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.32 26.48 15.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.42 -111.0 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.55 26.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.671 -0.9 . . . . 0.0 110.971 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -52.98 -30.16 33.34 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.96 -1.088 . . . . 0.0 109.716 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.46 75.26 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -102.67 -40.36 6.65 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.39 -0.819 . . . . 0.0 109.542 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 120.83 0.71 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 26' ' ' CYS . 20.0 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.577 -0.954 . . . . 0.0 109.42 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.63 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.67 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.238 . . . . 0.0 109.215 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -172.16 133.49 0.69 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.934 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -76.09 138.71 40.98 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 20' ' ' ILE . 53.9 m -48.04 -58.45 4.45 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.301 -0.874 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.04 64.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.36 45.28 0.8 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -162.95 75.1 0.4 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.627 -0.925 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.3 -26.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -0.769 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -62.7 -37.52 86.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -107.4 128.21 54.27 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.393 -0.817 . . . . 0.0 109.921 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.6 p -120.49 168.74 11.02 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.28 167.73 13.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.2 Cg_endo -74.36 163.55 36.04 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.593 1.529 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.29 -27.02 68.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.65 -0.656 . . . . 0.0 109.305 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.31 -31.37 68.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.2 m95 -80.94 2.19 27.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.453 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 6.2 tpt180 -77.47 138.84 39.47 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.9 t 85.38 -51.43 0.08 Allowed 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.82 -77.74 0.47 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.99 -0.16 47.85 Favored Glycine 0 N--CA 1.488 2.105 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.106 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.675 ' O ' HG23 ' A' ' 30' ' ' VAL . 5.2 mt-30 52.55 -113.49 0.76 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 29' ' ' GLN . 16.4 t -152.33 69.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.478 1.132 . . . . 0.0 108.611 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 36.9 t70 -100.99 23.57 10.53 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.863 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 m -132.81 -165.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.93 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.4 -80.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.697 . . . . 0.0 109.759 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -106.54 28.53 7.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.847 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.13 41.41 7.07 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -22.52 64.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.538 -0.977 . . . . 0.0 109.517 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p30 -53.76 -25.69 20.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.079 -1.013 . . . . 0.0 109.598 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.14 48.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.57 108.05 19.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 110.231 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.74 -66.22 1.39 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 38.6 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.87 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.82 -168.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -165.93 108.27 0.76 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.78 108.33 1.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.513 ' HB2' HD11 ' A' ' 20' ' ' ILE . 35.1 t -49.54 -56.85 8.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.749 -0.594 . . . . 0.0 110.826 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.63 174.99 13.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -168.57 43.12 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -173.14 1.0 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.952 . . . . 0.0 109.25 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.4 p 37.86 94.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.189 0.995 . . . . 0.0 111.8 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.01 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.366 0.603 . . . . 0.0 110.928 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.68 112.58 19.46 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.06 169.35 10.48 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.419 -0.801 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.719 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -147.78 175.11 2.9 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.56 ' CD ' HG22 ' A' ' 20' ' ' ILE . 32.6 Cg_endo -77.02 152.63 31.77 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 121.561 1.508 . . . . 0.0 110.015 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.34 -19.64 56.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 109.971 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -77.18 -31.77 55.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.463 -0.773 . . . . 0.0 110.332 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 31' ' ' ASP . 5.0 m95 -73.68 -6.05 44.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 110.847 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG2' ' CG ' ' A' ' 10' ' ' PHE . 3.1 mmm-85 -70.11 131.55 44.47 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 12.4 t 87.71 -50.04 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.2 38.03 1.95 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . -53.92 -22.78 20.74 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 30' ' ' VAL . 5.4 mt-30 60.96 -122.76 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 30' ' ' VAL . 55.3 t -145.56 55.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 120.482 1.492 . . . . 0.0 109.908 176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 29.2 t70 -77.23 -7.94 56.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 58.6 m -102.24 -9.27 20.57 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.243 -0.911 . . . . 0.0 110.683 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 56.56 86.29 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 59.47 25.42 14.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 109.71 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -88.64 -114.97 1.29 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -161.56 17.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.508 -0.995 . . . . 0.0 112.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 10.0 p30 -59.24 -21.74 60.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.519 -1.363 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.63 42.83 3.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.428 -0.795 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -91.95 -48.25 6.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 0.0 109.549 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.43 127.73 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.435 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.674 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -168.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.072 -1.252 . . . . 0.0 108.795 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -173.64 120.22 0.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.592 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m -65.66 137.04 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 29.5 m -49.9 -38.31 35.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.24 50.81 0.41 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.73 -34.22 0.32 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.97 136.98 56.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -1.031 . . . . 0.0 109.741 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 17' ' ' ASN . 9.2 p -63.6 -39.1 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.688 -0.633 . . . . 0.0 109.598 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -144.08 98.06 3.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.677 . . . . 0.0 109.797 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -175.48 144.18 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 172.42 12.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.835 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.722 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -151.61 166.77 14.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 20' ' ' ILE . 29.9 Cg_endo -73.84 162.66 38.87 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.582 1.522 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.82 71.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.984 0.897 . . . . 0.0 109.782 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.18 -39.35 92.39 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.479 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.2 m95 -76.35 -6.84 53.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.18 -0.95 . . . . 0.0 110.968 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 1.5 tpt180 -70.95 141.36 51.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 2.0 t 85.35 -51.13 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.51 -79.37 0.45 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 74.87 -6.85 24.19 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.626 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER 53.09 -112.37 0.69 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.305 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 29' ' ' GLN . 38.4 t -151.04 66.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.431 1.11 . . . . 0.0 108.423 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 25.5 t0 -97.58 24.88 6.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 20' ' ' ILE . 68.7 m -136.6 13.25 3.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.687 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 39.23 78.62 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 O-C-N 121.771 -0.581 . . . . 0.0 111.257 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 23.04 10.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.736 . . . . 0.0 109.251 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.27 -104.12 0.1 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.33 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -1.028 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 6.5 p30 -55.17 -23.14 20.15 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.755 -1.216 . . . . 0.0 110.012 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -127.25 46.26 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -114.27 -42.7 3.3 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.587 -0.696 . . . . 0.0 109.94 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.87 -40.97 34.77 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 26' ' ' CYS . 34.6 t . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.17 43.32 14.2 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.416 -0.803 . . . . 0.0 109.514 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.32 152.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.967 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 p -123.84 156.27 36.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.603 -0.686 . . . . 0.0 109.324 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.42 22.52 15.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.541 -0.724 . . . . 0.0 109.975 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 58.1 -170.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -102.91 140.54 37.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.608 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.11 10.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.88 -165.41 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.451 -1.029 . . . . 0.0 109.293 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -172.99 109.14 0.18 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.6 p -68.54 120.28 14.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 28.5 t -49.28 -65.4 0.57 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 110.833 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.36 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.4 25.89 72.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.33 72.96 0.49 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.387 -1.067 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 17' ' ' ASN . 9.9 p -57.35 -23.6 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' CG ' HG13 ' A' ' 16' ' ' VAL . 3.1 p30 179.68 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.354 -0.841 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -155.45 -175.63 5.53 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.61 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.23 175.35 6.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.669 -0.644 . . . . 0.0 109.322 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 24' ' ' TRP . 37.8 mm -130.28 139.8 36.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.8 Cg_endo -71.06 159.1 53.39 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.414 1.409 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.35 -26.64 63.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.553 -0.717 . . . . 0.0 109.073 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.05 -39.34 83.03 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.707 -0.621 . . . . 0.0 109.484 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.549 ' CE3' ' HB2' ' A' ' 31' ' ' ASP . 11.9 m95 -81.37 -3.99 54.39 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 24.9 tpt180 -76.35 148.92 37.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.388 -1.445 . . . . 0.0 107.504 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 5.1 t 86.27 -56.32 0.06 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.47 -76.17 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.89 -18.45 39.61 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.5 OUTLIER 57.25 -111.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 30' ' ' VAL . 71.0 t -148.43 53.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 122.551 1.167 . . . . 0.0 108.862 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 7.7 t70 -73.54 -9.12 58.35 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HA ' HG11 ' A' ' 16' ' ' VAL . 61.1 m -92.51 -13.28 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.42 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -107.11 38.95 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 108.76 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.48 -136.23 5.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.93 68.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.958 . . . . 0.0 110.538 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -33.22 19.92 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.852 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -98.83 65.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.324 0.583 . . . . 0.0 109.697 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -101.72 62.07 0.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.17 105.54 1.37 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.7 m -129.23 102.06 6.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.536 -0.727 . . . . 0.0 109.564 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.2 p -58.79 101.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.563 -0.71 . . . . 0.0 109.548 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -144.26 167.28 22.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.661 -0.649 . . . . 0.0 109.267 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 4' ' ' THR . 21.1 m 84.05 -51.36 0.13 Allowed 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 122.663 0.385 . . . . 0.0 110.685 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 67.11 -166.14 0.21 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.244 -0.91 . . . . 0.0 108.929 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 p -77.22 152.94 34.51 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 0.0 109.894 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.75 37.21 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.4 -163.38 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -1.076 . . . . 0.0 109.552 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -169.93 127.26 0.87 Allowed 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.937 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.0 t -70.51 136.89 49.74 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 20' ' ' ILE . 82.4 m -47.15 -60.91 2.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 0.0 110.781 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.32 -47.04 0.03 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.57 136.82 13.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -71.89 98.41 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.579 -0.954 . . . . 0.0 109.454 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 16' ' ' VAL . 47.5 t -139.54 49.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 121.548 -0.72 . . . . 0.0 109.694 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 59.69 59.9 2.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -166.37 103.35 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 p -117.8 169.35 9.68 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.78 0.8 . . . . 0.0 110.311 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.13 166.8 15.79 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.5 Cg_endo -74.71 167.69 26.52 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.482 1.455 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -25.93 65.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -71.31 -21.61 62.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.736 . . . . 0.0 109.892 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.611 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 8.1 m95 -91.32 20.84 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.071 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 10' ' ' PHE . 12.1 mmm-85 -97.28 139.22 33.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 21.3 m 86.72 -54.64 0.06 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -93.74 -76.24 0.48 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 24' ' ' TRP . . . 69.96 0.3 26.3 Favored Glycine 0 N--CA 1.487 2.084 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.809 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 52.49 -120.2 1.63 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 29' ' ' GLN . 25.5 t -149.96 68.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 120.068 1.304 . . . . 0.0 108.885 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.94 26.25 5.94 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.0 m -134.61 178.49 6.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.839 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.4 -78.37 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.9 40.16 1.31 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.48 49.45 76.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -3.13 56.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.671 -0.899 . . . . 0.0 110.449 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.27 -25.71 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.035 -1.04 . . . . 0.0 109.967 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -120.37 63.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.655 -0.653 . . . . 0.0 109.412 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.71 -55.6 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.53 6.35 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.473 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m 58.67 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' HD3' ' A' ' 6' ' ' LYS . 9.0 p -58.42 153.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.957 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -140.18 142.99 35.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.691 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m 59.22 80.45 0.19 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.792 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HD3' HG13 ' A' ' 3' ' ' VAL . 5.3 pttm -137.42 63.78 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.796 . . . . 0.0 109.663 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.85 -73.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.555 -0.716 . . . . 0.0 109.218 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.86 24.7 2.27 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.9 -168.76 2.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -1.043 . . . . 0.0 109.243 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -173.2 121.91 0.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.57 135.86 50.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 20' ' ' ILE . 67.9 m -47.16 -67.83 0.24 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.484 -0.76 . . . . 0.0 111.095 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.5 -89.95 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.82 32.09 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -125.97 160.57 29.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.946 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 16' ' ' VAL . 7.2 p -89.44 57.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 O-C-N 121.648 -0.657 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -105.1 -42.02 5.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 109.748 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -142.88 -178.94 6.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.514 -0.741 . . . . 0.0 109.77 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.58 156.02 40.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.655 -0.653 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -150.21 163.85 22.81 Favored Pre-proline 0 N--CA 1.501 2.122 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 20' ' ' ILE . 30.7 Cg_endo -74.31 162.0 39.3 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 122.003 1.802 . . . . 0.0 111.21 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.24 -28.8 67.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.689 -0.632 . . . . 0.0 109.708 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.0 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 109.622 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.4 m95 -75.36 -5.69 46.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 110.05 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 28.1 tpt180 -71.98 143.19 49.31 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 17.9 m 85.39 -56.25 0.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.29 -78.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.9 -1.18 40.85 Favored Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.086 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 30' ' ' VAL . 5.1 mt-30 52.49 -110.58 0.53 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 29' ' ' GLN . 12.9 t -154.23 72.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.371 1.081 . . . . 0.0 108.575 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 37.8 t70 -104.56 31.59 4.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.1 m -130.35 172.51 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.677 -0.639 . . . . 0.0 110.322 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.2 -39.25 78.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.598 -0.689 . . . . 0.0 110.572 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -139.24 31.08 2.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 109.711 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.01 41.84 92.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -10.93 59.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -1.009 . . . . 0.0 109.762 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.5 p30 -51.6 -26.01 8.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -97.24 54.56 1.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.66 55.26 2.15 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.431 -0.793 . . . . 0.0 109.63 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.35 127.21 0.69 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -167.8 138.09 2.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 109.79 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.45 -24.59 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 110.073 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.1 -90.55 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 0.0 110.733 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.48 34.28 24.4 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.968 -1.082 . . . . 0.0 109.28 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.02 -161.97 0.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 p -118.63 162.69 17.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.387 -0.82 . . . . 0.0 109.97 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.29 25.15 68.11 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -109.76 -168.4 1.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.432 -1.04 . . . . 0.0 109.212 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -176.37 133.74 0.23 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.628 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -81.06 138.17 35.99 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.711 ' SG ' HD11 ' A' ' 20' ' ' ILE . 59.1 m -48.4 -38.34 19.31 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.333 -0.855 . . . . 0.0 110.386 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.15 -125.2 2.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.04 -105.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -135.67 53.97 1.93 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.959 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.0 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.408 -0.808 . . . . 0.0 109.95 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 179.86 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.413 -0.804 . . . . 0.0 109.711 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 158.7 32.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.661 . . . . 0.0 110.127 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 158.21 44.85 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.711 HD11 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -150.83 163.83 22.44 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.366 -0.834 . . . . 0.0 108.791 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.7 Cg_endo -74.77 164.2 34.12 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.939 1.759 . . . . 0.0 110.715 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -27.94 69.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.601 -0.687 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -66.29 -37.19 84.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.584 -0.698 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.1 m95 -76.35 -9.99 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.219 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.1 tpt180 -70.73 146.04 50.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 22.6 m 85.88 -58.78 0.07 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.25 -77.85 0.41 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 79.85 -8.84 48.04 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.541 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 30' ' ' VAL . 4.7 mt-30 55.97 -113.18 0.76 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 30' ' ' VAL . 37.3 t -151.09 63.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.548 1.166 . . . . 0.0 108.48 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 27.2 t70 -84.56 2.31 41.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.473 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -136.41 24.2 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.0 -1.062 . . . . 0.0 110.112 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.26 63.56 2.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.0 110.426 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.27 24.84 4.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.95 -92.55 0.04 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -145.09 0.84 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.966 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -61.39 -24.01 66.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.472 -1.393 . . . . 0.0 108.94 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.26 40.99 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.85 -64.99 1.07 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.656 -0.653 . . . . 0.0 109.997 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.3 128.36 1.8 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.405 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 1' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -116.84 79.39 1.32 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.549 -0.719 . . . . 0.0 109.344 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 3' ' ' VAL . 10.8 p 40.5 35.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.019 0.438 . . . . 0.0 112.061 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -143.45 133.79 24.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 9' ' ' ASP . 26.3 p 35.68 69.74 0.17 Allowed 'General case' 0 N--CA 1.511 2.616 0 CA-C-O 121.247 0.546 . . . . 0.0 112.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -95.68 53.1 1.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m -146.53 77.24 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 109.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.23 18.5 60.63 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 5' ' ' CYS . 8.7 m-20 -105.43 -167.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -1.085 . . . . 0.0 108.847 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -172.95 125.91 0.45 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.6 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 p -67.24 130.63 43.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.601 ' SG ' HD11 ' A' ' 20' ' ' ILE . 60.1 m -51.05 -46.92 61.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 51.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.92 -166.21 22.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.459 ' O ' HG12 ' A' ' 16' ' ' VAL . 9.7 mmt180 -102.21 122.83 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.56 -0.965 . . . . 0.0 109.728 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.576 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.6 p 41.05 34.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -77.38 -66.86 0.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.436 -0.79 . . . . 0.0 108.923 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -171.73 141.75 1.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -99.4 169.51 9.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.483 -0.761 . . . . 0.0 110.369 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.659 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -152.03 169.87 8.84 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.4 Cg_endo -75.5 163.85 33.51 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.975 1.783 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -61.78 -28.21 69.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.692 -0.63 . . . . 0.0 109.524 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -65.84 -44.21 86.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.58 -0.7 . . . . 0.0 109.672 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.519 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.7 m95 -70.73 -9.43 57.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.474 -0.766 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.487 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.0 tpt85 -69.25 143.15 54.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.8 t 84.93 -57.47 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -78.69 0.44 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.14 -2.49 35.3 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.034 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.678 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 55.68 -114.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 29' ' ' GLN . 14.8 t -153.0 71.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 119.631 1.105 . . . . 0.0 108.279 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 23.4 t0 -96.84 20.49 10.95 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -156.51 101.77 2.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.11 -0.994 . . . . 0.0 111.43 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.19 -148.31 0.32 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.391 -0.818 . . . . 0.0 109.966 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -54.4 -24.61 20.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.899 -1.126 . . . . 0.0 109.786 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.25 73.36 0.07 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 39' ' ' GLN . 2.4 p -91.8 -13.77 30.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.357 -1.084 . . . . 0.0 109.541 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 1.4 p30 -54.53 -30.04 52.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.607 -1.308 . . . . 0.0 108.61 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.88 49.58 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 36' ' ' SER . 3.2 tt0 -101.03 71.83 1.43 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.84 84.73 1.55 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.528 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.128 0.489 . . . . 0.0 109.901 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 p -118.54 -43.6 2.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.279 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.04 -25.55 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.623 -0.673 . . . . 0.0 109.973 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -170.94 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.83 22.84 12.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.667 . . . . 0.0 110.134 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.89 -161.75 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.231 -0.918 . . . . 0.0 109.67 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.7 m -100.66 166.99 10.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.11 40.85 99.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -172.3 4.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.978 . . . . 0.0 108.624 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -177.6 135.56 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -87.66 123.08 32.13 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.744 ' HB3' HD11 ' A' ' 20' ' ' ILE . 7.1 p -52.45 -35.89 53.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.352 -0.843 . . . . 0.0 110.101 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.09 114.4 0.48 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.89 -171.31 35.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -109.55 79.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.559 -0.965 . . . . 0.0 109.432 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 16' ' ' VAL . 13.9 p -94.93 26.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.512 -0.743 . . . . 0.0 110.154 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.72 31.83 18.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.317 -0.865 . . . . 0.0 109.644 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HB2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -140.09 112.31 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -109.42 172.41 6.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.562 -0.711 . . . . 0.0 110.392 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -149.14 163.45 25.28 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.0 Cg_endo -75.3 163.18 35.15 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.882 1.721 . . . . 0.0 110.794 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.76 -26.67 65.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.568 -0.708 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -67.34 -41.75 84.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.603 . . . . 0.0 109.7 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.0 m95 -72.56 -11.29 60.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.474 -0.766 . . . . 0.0 110.365 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 9.0 tpt180 -69.51 139.96 53.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER 85.99 -54.84 0.07 Allowed 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -178.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -102.37 -78.98 0.53 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 59.75 12.52 21.01 Favored Glycine 0 N--CA 1.487 2.066 0 CA-C-O 119.043 -0.865 . . . . 0.0 111.433 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER 51.87 -119.24 1.42 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -176.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 30' ' ' VAL . 40.7 t -149.92 59.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.771 1.272 . . . . 0.0 108.254 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 12.4 t0 -65.14 -16.17 63.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.853 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 1.4 m -117.16 95.99 5.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.68 130.01 41.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.94 24.68 14.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 109.241 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -108.77 -120.63 4.41 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.48 32.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 111.634 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.2 -23.85 16.08 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.603 -1.311 . . . . 0.0 109.544 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.26 60.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.15 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -99.28 -51.7 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.26 47.87 2.64 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.456 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 t -157.67 30.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.77 -14.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.626 -0.671 . . . . 0.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.58 -78.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 0.0 110.102 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.12 59.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 109.758 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt 57.64 -174.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -102.38 44.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.48 -51.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 -164.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.643 -0.916 . . . . 0.0 108.762 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.508 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -174.54 120.72 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.651 -0.655 . . . . 0.0 109.691 178.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -70.68 134.01 47.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.2 m -46.91 -44.82 20.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.562 -0.711 . . . . 0.0 111.222 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.44 43.82 0.02 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.19 -174.25 23.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 58.68 104.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.941 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.66 -25.88 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 0.0 110.294 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -89.72 162.9 15.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.33 -0.856 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 64.23 138.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.749 -0.594 . . . . 0.0 110.251 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.2 -178.03 5.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.269 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 24' ' ' TRP . 41.1 mm -133.58 141.9 41.91 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 28.4 Cg_endo -69.42 157.81 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.451 1.434 . . . . 0.0 111.304 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -53.41 -36.79 61.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.074 0.94 . . . . 0.0 109.621 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -63.39 -41.1 98.75 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.382 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.4 m95 -78.73 -3.53 44.68 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.065 -1.022 . . . . 0.0 110.342 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' CE2' ' A' ' 10' ' ' PHE . 15.9 tpt180 -75.55 151.13 37.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 24.0 m 85.82 -55.39 0.08 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.55 -73.9 0.5 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . 94.31 -26.9 15.21 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 30' ' ' VAL . 8.6 mt-30 56.33 -117.24 1.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -176.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 53.6 t -147.63 55.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 122.936 1.351 . . . . 0.0 107.46 174.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -90.3 15.02 11.23 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.026 178.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.0 m -126.97 12.69 7.25 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 50.96 62.13 2.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.159 -0.963 . . . . 0.0 109.609 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.32 26.48 15.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.42 -111.0 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.55 26.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.671 -0.9 . . . . 0.0 110.971 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -52.98 -30.16 33.34 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.96 -1.088 . . . . 0.0 109.716 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.46 75.26 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -102.67 -40.36 6.65 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.39 -0.819 . . . . 0.0 109.542 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 120.83 0.71 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 26' ' ' CYS . 20.0 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.577 -0.954 . . . . 0.0 109.42 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 1' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p 55.69 178.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.661 -0.65 . . . . 0.0 110.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.496 HG22 HG23 ' A' ' 4' ' ' THR . 13.3 p -70.26 164.97 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.704 -0.622 . . . . 0.0 110.251 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.496 HG23 HG22 ' A' ' 3' ' ' VAL . 10.6 p 57.02 -167.26 0.12 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.421 0.629 . . . . 0.0 110.401 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.64 24.31 4.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.665 -0.647 . . . . 0.0 110.147 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.06 177.03 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.863 . . . . 0.0 109.732 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -89.83 165.07 14.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.599 -0.688 . . . . 0.0 110.113 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.03 83.56 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.67 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.238 . . . . 0.0 109.215 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -172.16 133.49 0.69 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.934 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -76.09 138.71 40.98 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 20' ' ' ILE . 53.9 m -48.04 -58.45 4.45 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.301 -0.874 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.04 64.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.36 45.28 0.8 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -162.95 75.1 0.4 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.627 -0.925 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.3 -26.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -0.769 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -62.7 -37.52 86.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -107.4 128.21 54.27 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.393 -0.817 . . . . 0.0 109.921 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.6 p -120.49 168.74 11.02 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.28 167.73 13.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.2 Cg_endo -74.36 163.55 36.04 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.593 1.529 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.29 -27.02 68.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.65 -0.656 . . . . 0.0 109.305 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.31 -31.37 68.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.2 m95 -80.94 2.19 27.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.453 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 6.2 tpt180 -77.47 138.84 39.47 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.9 t 85.38 -51.43 0.08 Allowed 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.82 -77.74 0.47 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.99 -0.16 47.85 Favored Glycine 0 N--CA 1.488 2.105 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.106 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.675 ' O ' HG23 ' A' ' 30' ' ' VAL . 5.2 mt-30 52.55 -113.49 0.76 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 -176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 29' ' ' GLN . 16.4 t -152.33 69.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.478 1.132 . . . . 0.0 108.611 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 36.9 t70 -100.99 23.57 10.53 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.863 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 m -132.81 -165.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.93 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.4 -80.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.697 . . . . 0.0 109.759 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -106.54 28.53 7.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.847 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.13 41.41 7.07 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -22.52 64.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.538 -0.977 . . . . 0.0 109.517 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p30 -53.76 -25.69 20.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.079 -1.013 . . . . 0.0 109.598 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.14 48.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.57 108.05 19.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 110.231 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.74 -66.22 1.39 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 38.6 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.87 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -143.67 24.94 1.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 109.864 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 4' ' ' THR . 9.2 p -62.58 125.68 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -160.23 -175.69 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 86.0 m 57.93 82.53 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.808 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.78 94.87 3.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.597 -0.689 . . . . 0.0 109.84 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.47 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.758 . . . . 0.0 109.665 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.42 26.01 14.7 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.82 -168.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -165.93 108.27 0.76 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.78 108.33 1.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.513 ' HB2' HD11 ' A' ' 20' ' ' ILE . 35.1 t -49.54 -56.85 8.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.749 -0.594 . . . . 0.0 110.826 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.63 174.99 13.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -168.57 43.12 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -173.14 1.0 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.952 . . . . 0.0 109.25 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.4 p 37.86 94.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.189 0.995 . . . . 0.0 111.8 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.01 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.366 0.603 . . . . 0.0 110.928 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.68 112.58 19.46 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.06 169.35 10.48 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.419 -0.801 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.719 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -147.78 175.11 2.9 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' CD ' HG22 ' A' ' 20' ' ' ILE . 32.6 Cg_endo -77.02 152.63 31.77 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 121.561 1.508 . . . . 0.0 110.015 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.34 -19.64 56.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 109.971 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -77.18 -31.77 55.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.463 -0.773 . . . . 0.0 110.332 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 31' ' ' ASP . 5.0 m95 -73.68 -6.05 44.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 110.847 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG2' ' CG ' ' A' ' 10' ' ' PHE . 3.1 mmm-85 -70.11 131.55 44.47 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 12.4 t 87.71 -50.04 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.2 38.03 1.95 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . -53.92 -22.78 20.74 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 30' ' ' VAL . 5.4 mt-30 60.96 -122.76 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 30' ' ' VAL . 55.3 t -145.56 55.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 120.482 1.492 . . . . 0.0 109.908 176.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 29.2 t70 -77.23 -7.94 56.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 58.6 m -102.24 -9.27 20.57 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.243 -0.911 . . . . 0.0 110.683 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 56.56 86.29 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 59.47 25.42 14.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 109.71 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -88.64 -114.97 1.29 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -161.56 17.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.508 -0.995 . . . . 0.0 112.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 10.0 p30 -59.24 -21.74 60.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.519 -1.363 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.63 42.83 3.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.428 -0.795 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -91.95 -48.25 6.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 0.0 109.549 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.43 127.73 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.435 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -64.76 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.6 -0.687 . . . . 0.0 109.307 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 3' ' ' VAL . 9.8 p -58.3 121.82 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.534 -0.729 . . . . 0.0 109.862 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.23 -50.33 1.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.496 -0.753 . . . . 0.0 109.326 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.32 -73.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.05 -45.94 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 t -176.03 -66.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 110.498 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.22 -3.96 50.73 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.156 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -168.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.072 -1.252 . . . . 0.0 108.795 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -173.64 120.22 0.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.592 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m -65.66 137.04 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 29.5 m -49.9 -38.31 35.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.24 50.81 0.41 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.73 -34.22 0.32 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.97 136.98 56.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -1.031 . . . . 0.0 109.741 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 17' ' ' ASN . 9.2 p -63.6 -39.1 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.688 -0.633 . . . . 0.0 109.598 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -144.08 98.06 3.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.677 . . . . 0.0 109.797 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -175.48 144.18 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 172.42 12.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.835 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.722 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -151.61 166.77 14.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 20' ' ' ILE . 29.9 Cg_endo -73.84 162.66 38.87 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.582 1.522 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.82 71.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.984 0.897 . . . . 0.0 109.782 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.18 -39.35 92.39 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.479 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.2 m95 -76.35 -6.84 53.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.18 -0.95 . . . . 0.0 110.968 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 1.5 tpt180 -70.95 141.36 51.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 2.0 t 85.35 -51.13 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.51 -79.37 0.45 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 74.87 -6.85 24.19 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.626 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER 53.09 -112.37 0.69 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.305 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 29' ' ' GLN . 38.4 t -151.04 66.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.431 1.11 . . . . 0.0 108.423 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 25.5 t0 -97.58 24.88 6.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 20' ' ' ILE . 68.7 m -136.6 13.25 3.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.687 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 39.23 78.62 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 O-C-N 121.771 -0.581 . . . . 0.0 111.257 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 23.04 10.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.736 . . . . 0.0 109.251 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.27 -104.12 0.1 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.33 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -1.028 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 6.5 p30 -55.17 -23.14 20.15 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.755 -1.216 . . . . 0.0 110.012 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -127.25 46.26 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -114.27 -42.7 3.3 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.587 -0.696 . . . . 0.0 109.94 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.87 -40.97 34.77 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 26' ' ' CYS . 34.6 t . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.506 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.88 -165.41 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.451 -1.029 . . . . 0.0 109.293 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -172.99 109.14 0.18 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.6 p -68.54 120.28 14.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 28.5 t -49.28 -65.4 0.57 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 110.833 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.36 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.4 25.89 72.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.33 72.96 0.49 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.387 -1.067 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 17' ' ' ASN . 9.9 p -57.35 -23.6 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' CG ' HG13 ' A' ' 16' ' ' VAL . 3.1 p30 179.68 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.354 -0.841 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -155.45 -175.63 5.53 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.61 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.23 175.35 6.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.669 -0.644 . . . . 0.0 109.322 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 24' ' ' TRP . 37.8 mm -130.28 139.8 36.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.8 Cg_endo -71.06 159.1 53.39 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.414 1.409 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.35 -26.64 63.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.553 -0.717 . . . . 0.0 109.073 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.05 -39.34 83.03 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.707 -0.621 . . . . 0.0 109.484 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.549 ' CE3' ' HB2' ' A' ' 31' ' ' ASP . 11.9 m95 -81.37 -3.99 54.39 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.491 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 24.9 tpt180 -76.35 148.92 37.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.388 -1.445 . . . . 0.0 107.504 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 5.1 t 86.27 -56.32 0.06 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.47 -76.17 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.89 -18.45 39.61 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.5 OUTLIER 57.25 -111.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 30' ' ' VAL . 71.0 t -148.43 53.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 122.551 1.167 . . . . 0.0 108.862 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 7.7 t70 -73.54 -9.12 58.35 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HA ' HG11 ' A' ' 16' ' ' VAL . 61.1 m -92.51 -13.28 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.42 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -107.11 38.95 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 108.76 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.48 -136.23 5.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.93 68.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.958 . . . . 0.0 110.538 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -33.22 19.92 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.852 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -98.83 65.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.324 0.583 . . . . 0.0 109.697 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -101.72 62.07 0.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.17 105.54 1.37 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.539 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.4 -163.38 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -1.076 . . . . 0.0 109.552 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -169.93 127.26 0.87 Allowed 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.937 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.0 t -70.51 136.89 49.74 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 20' ' ' ILE . 82.4 m -47.15 -60.91 2.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 0.0 110.781 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.32 -47.04 0.03 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.57 136.82 13.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -71.89 98.41 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.579 -0.954 . . . . 0.0 109.454 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 16' ' ' VAL . 47.5 t -139.54 49.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 121.548 -0.72 . . . . 0.0 109.694 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 59.69 59.9 2.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -166.37 103.35 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 p -117.8 169.35 9.68 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.78 0.8 . . . . 0.0 110.311 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.13 166.8 15.79 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.5 Cg_endo -74.71 167.69 26.52 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.482 1.455 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -25.93 65.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -71.31 -21.61 62.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.736 . . . . 0.0 109.892 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.611 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 8.1 m95 -91.32 20.84 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.071 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 10' ' ' PHE . 12.1 mmm-85 -97.28 139.22 33.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 21.3 m 86.72 -54.64 0.06 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -93.74 -76.24 0.48 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 24' ' ' TRP . . . 69.96 0.3 26.3 Favored Glycine 0 N--CA 1.487 2.084 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.809 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 52.49 -120.2 1.63 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 29' ' ' GLN . 25.5 t -149.96 68.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 120.068 1.304 . . . . 0.0 108.885 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.94 26.25 5.94 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.0 m -134.61 178.49 6.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.839 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.4 -78.37 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.9 40.16 1.31 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.48 49.45 76.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -3.13 56.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.671 -0.899 . . . . 0.0 110.449 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.27 -25.71 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.035 -1.04 . . . . 0.0 109.967 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -120.37 63.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.655 -0.653 . . . . 0.0 109.412 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.71 -55.6 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.53 6.35 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.473 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.497 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.9 -168.76 2.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -1.043 . . . . 0.0 109.243 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -173.2 121.91 0.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.57 135.86 50.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 20' ' ' ILE . 67.9 m -47.16 -67.83 0.24 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.484 -0.76 . . . . 0.0 111.095 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.5 -89.95 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.82 32.09 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -125.97 160.57 29.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.946 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 16' ' ' VAL . 7.2 p -89.44 57.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 O-C-N 121.648 -0.657 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -105.1 -42.02 5.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 109.748 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -142.88 -178.94 6.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.514 -0.741 . . . . 0.0 109.77 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.58 156.02 40.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.655 -0.653 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -150.21 163.85 22.81 Favored Pre-proline 0 N--CA 1.501 2.122 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 20' ' ' ILE . 30.7 Cg_endo -74.31 162.0 39.3 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 122.003 1.802 . . . . 0.0 111.21 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.24 -28.8 67.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.689 -0.632 . . . . 0.0 109.708 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.0 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 109.622 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.4 m95 -75.36 -5.69 46.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 110.05 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 28.1 tpt180 -71.98 143.19 49.31 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 17.9 m 85.39 -56.25 0.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.29 -78.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.9 -1.18 40.85 Favored Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.086 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 30' ' ' VAL . 5.1 mt-30 52.49 -110.58 0.53 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 29' ' ' GLN . 12.9 t -154.23 72.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.371 1.081 . . . . 0.0 108.575 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 37.8 t70 -104.56 31.59 4.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.1 m -130.35 172.51 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.677 -0.639 . . . . 0.0 110.322 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.2 -39.25 78.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.598 -0.689 . . . . 0.0 110.572 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -139.24 31.08 2.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 109.711 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.01 41.84 92.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -10.93 59.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -1.009 . . . . 0.0 109.762 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.5 p30 -51.6 -26.01 8.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -97.24 54.56 1.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.66 55.26 2.15 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.431 -0.793 . . . . 0.0 109.63 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.35 127.21 0.69 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.423 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -109.76 -168.4 1.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.432 -1.04 . . . . 0.0 109.212 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -176.37 133.74 0.23 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.628 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -81.06 138.17 35.99 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.711 ' SG ' HD11 ' A' ' 20' ' ' ILE . 59.1 m -48.4 -38.34 19.31 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.333 -0.855 . . . . 0.0 110.386 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.15 -125.2 2.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.04 -105.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -135.67 53.97 1.93 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.959 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.0 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.408 -0.808 . . . . 0.0 109.95 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 179.86 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.413 -0.804 . . . . 0.0 109.711 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 158.7 32.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.661 . . . . 0.0 110.127 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 158.21 44.85 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.711 HD11 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -150.83 163.83 22.44 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.366 -0.834 . . . . 0.0 108.791 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.7 Cg_endo -74.77 164.2 34.12 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.939 1.759 . . . . 0.0 110.715 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -27.94 69.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.601 -0.687 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -66.29 -37.19 84.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.584 -0.698 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.1 m95 -76.35 -9.99 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.219 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.1 tpt180 -70.73 146.04 50.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 22.6 m 85.88 -58.78 0.07 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.25 -77.85 0.41 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 79.85 -8.84 48.04 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.541 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 30' ' ' VAL . 3.1 mt-30 55.97 -113.18 0.76 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 30' ' ' VAL . 37.3 t -151.09 63.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.548 1.166 . . . . 0.0 108.48 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 27.2 t70 -84.56 2.31 41.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.473 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -136.41 24.2 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.0 -1.062 . . . . 0.0 110.112 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.26 63.56 2.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.0 110.426 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.27 24.84 4.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.95 -92.55 0.04 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -145.09 0.84 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.966 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -61.39 -24.01 66.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.472 -1.393 . . . . 0.0 108.94 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.26 40.99 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.85 -64.99 1.07 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.656 -0.653 . . . . 0.0 109.997 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.3 128.36 1.8 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.405 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.43 -167.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -1.085 . . . . 0.0 108.847 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -172.95 125.91 0.45 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.6 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 p -67.24 130.63 43.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.601 ' SG ' HD11 ' A' ' 20' ' ' ILE . 60.1 m -51.05 -46.92 61.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 51.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.92 -166.21 22.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.459 ' O ' HG12 ' A' ' 16' ' ' VAL . 9.7 mmt180 -102.21 122.83 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.56 -0.965 . . . . 0.0 109.728 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.576 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.6 p 41.05 34.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -77.38 -66.86 0.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.436 -0.79 . . . . 0.0 108.923 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -171.73 141.75 1.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -99.4 169.51 9.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.483 -0.761 . . . . 0.0 110.369 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.659 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -152.03 169.87 8.84 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.4 Cg_endo -75.5 163.85 33.51 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.975 1.783 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -61.78 -28.21 69.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.692 -0.63 . . . . 0.0 109.524 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -65.84 -44.21 86.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.58 -0.7 . . . . 0.0 109.672 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.519 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.7 m95 -70.73 -9.43 57.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.474 -0.766 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.487 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.0 tpt85 -69.25 143.15 54.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.8 t 84.93 -57.47 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -78.69 0.44 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.14 -2.49 35.3 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.034 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.678 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 55.68 -114.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 29' ' ' GLN . 14.8 t -153.0 71.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 119.631 1.105 . . . . 0.0 108.279 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 23.4 t0 -96.84 20.49 10.95 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -156.51 101.77 2.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.11 -0.994 . . . . 0.0 111.43 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.19 -148.31 0.32 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.391 -0.818 . . . . 0.0 109.966 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -54.4 -24.61 20.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.899 -1.126 . . . . 0.0 109.786 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.25 73.36 0.07 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 39' ' ' GLN . 2.4 p -91.8 -13.77 30.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.357 -1.084 . . . . 0.0 109.541 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 1.4 p30 -54.53 -30.04 52.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.607 -1.308 . . . . 0.0 108.61 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.88 49.58 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 36' ' ' SER . 3.2 tt0 -101.03 71.83 1.43 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.84 84.73 1.55 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.528 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.525 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -172.3 4.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.978 . . . . 0.0 108.624 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -177.6 135.56 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -87.66 123.08 32.13 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.744 ' HB3' HD11 ' A' ' 20' ' ' ILE . 7.1 p -52.45 -35.89 53.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.352 -0.843 . . . . 0.0 110.101 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.09 114.4 0.48 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.89 -171.31 35.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -109.55 79.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.559 -0.965 . . . . 0.0 109.432 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 16' ' ' VAL . 13.9 p -94.93 26.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.512 -0.743 . . . . 0.0 110.154 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.72 31.83 18.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.317 -0.865 . . . . 0.0 109.644 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HB2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -140.09 112.31 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -109.42 172.41 6.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.562 -0.711 . . . . 0.0 110.392 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -149.14 163.45 25.28 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.0 Cg_endo -75.3 163.18 35.15 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.882 1.721 . . . . 0.0 110.794 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.76 -26.67 65.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.568 -0.708 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -67.34 -41.75 84.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.603 . . . . 0.0 109.7 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.0 m95 -72.56 -11.29 60.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.474 -0.766 . . . . 0.0 110.365 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 9.0 tpt180 -69.51 139.96 53.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER 85.99 -54.84 0.07 Allowed 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -178.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -102.37 -78.98 0.53 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 59.75 12.52 21.01 Favored Glycine 0 N--CA 1.487 2.066 0 CA-C-O 119.043 -0.865 . . . . 0.0 111.433 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER 51.87 -119.24 1.42 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -176.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 30' ' ' VAL . 40.7 t -149.92 59.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.771 1.272 . . . . 0.0 108.254 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 12.4 t0 -65.14 -16.17 63.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.853 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 1.4 m -117.16 95.99 5.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.68 130.01 41.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.94 24.68 14.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 109.241 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -108.77 -120.63 4.41 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.48 32.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 111.634 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.2 -23.85 16.08 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.603 -1.311 . . . . 0.0 109.544 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.26 60.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.15 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -99.28 -51.7 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.26 47.87 2.64 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.456 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.577 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 -164.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.643 -0.916 . . . . 0.0 108.762 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.508 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -174.54 120.72 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.651 -0.655 . . . . 0.0 109.691 178.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -70.68 134.01 47.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.2 m -46.91 -44.82 20.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.562 -0.711 . . . . 0.0 111.222 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.44 43.82 0.02 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.19 -174.25 23.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 58.68 104.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.941 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.66 -25.88 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 0.0 110.294 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -89.72 162.9 15.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.33 -0.856 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 64.23 138.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.749 -0.594 . . . . 0.0 110.251 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.2 -178.03 5.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.269 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 24' ' ' TRP . 41.1 mm -133.58 141.9 41.91 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 28.4 Cg_endo -69.42 157.81 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.451 1.434 . . . . 0.0 111.304 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -53.41 -36.79 61.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.074 0.94 . . . . 0.0 109.621 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -63.39 -41.1 98.75 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.382 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.4 m95 -78.73 -3.53 44.68 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.065 -1.022 . . . . 0.0 110.342 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' CE2' ' A' ' 10' ' ' PHE . 15.9 tpt180 -75.55 151.13 37.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 24.0 m 85.82 -55.39 0.08 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.55 -73.9 0.5 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . 94.31 -26.9 15.21 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 30' ' ' VAL . 3.3 mt-30 56.33 -117.24 1.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -176.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 53.6 t -147.63 55.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 122.936 1.351 . . . . 0.0 107.46 174.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -90.3 15.02 11.23 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.026 178.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.0 m -126.97 12.69 7.25 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 50.96 62.13 2.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.159 -0.963 . . . . 0.0 109.609 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.32 26.48 15.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.42 -111.0 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.55 26.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.671 -0.9 . . . . 0.0 110.971 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -52.98 -30.16 33.34 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.96 -1.088 . . . . 0.0 109.716 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.46 75.26 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -102.67 -40.36 6.65 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.39 -0.819 . . . . 0.0 109.542 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 120.83 0.71 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 26' ' ' CYS . 20.0 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.577 -0.954 . . . . 0.0 109.42 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.63 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.67 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.238 . . . . 0.0 109.215 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.624 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -172.16 133.49 0.69 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.934 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -76.09 138.71 40.98 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 20' ' ' ILE . 53.9 m -48.04 -58.45 4.45 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.301 -0.874 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.04 64.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.36 45.28 0.8 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -162.95 75.1 0.4 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.627 -0.925 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.3 -26.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -0.769 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -62.7 -37.52 86.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -107.4 128.21 54.27 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.393 -0.817 . . . . 0.0 109.921 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.6 p -120.49 168.74 11.02 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.28 167.73 13.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.2 Cg_endo -74.36 163.55 36.04 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.593 1.529 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.29 -27.02 68.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.65 -0.656 . . . . 0.0 109.305 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.31 -31.37 68.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.2 m95 -80.94 2.19 27.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.453 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 6.2 tpt180 -77.47 138.84 39.47 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.9 t 85.38 -51.43 0.08 Allowed 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.82 -77.74 0.47 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.99 -0.16 47.85 Favored Glycine 0 N--CA 1.488 2.105 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.106 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.675 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.5 OUTLIER 52.55 -113.49 0.76 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 -176.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 29' ' ' GLN . 16.4 t -152.33 69.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.478 1.132 . . . . 0.0 108.611 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 36.9 t70 -100.99 23.57 10.53 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.863 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 m -132.81 -165.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.93 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.4 -80.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.697 . . . . 0.0 109.759 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -106.54 28.53 7.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.847 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.13 41.41 7.07 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -22.52 64.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.538 -0.977 . . . . 0.0 109.517 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p30 -53.76 -25.69 20.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.079 -1.013 . . . . 0.0 109.598 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.14 48.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.57 108.05 19.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 110.231 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.74 -66.22 1.39 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 38.6 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.87 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.482 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.82 -168.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -165.93 108.27 0.76 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.78 108.33 1.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.513 ' HB2' HD11 ' A' ' 20' ' ' ILE . 35.1 t -49.54 -56.85 8.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.749 -0.594 . . . . 0.0 110.826 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.63 174.99 13.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -168.57 43.12 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -173.14 1.0 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.952 . . . . 0.0 109.25 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.4 p 37.86 94.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.189 0.995 . . . . 0.0 111.8 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.01 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.366 0.603 . . . . 0.0 110.928 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.68 112.58 19.46 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.06 169.35 10.48 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.419 -0.801 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.719 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -147.78 175.11 2.9 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.56 ' CD ' HG22 ' A' ' 20' ' ' ILE . 32.6 Cg_endo -77.02 152.63 31.77 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 121.561 1.508 . . . . 0.0 110.015 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.34 -19.64 56.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 109.971 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -77.18 -31.77 55.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.463 -0.773 . . . . 0.0 110.332 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 31' ' ' ASP . 5.0 m95 -73.68 -6.05 44.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 110.847 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG2' ' CG ' ' A' ' 10' ' ' PHE . 3.1 mmm-85 -70.11 131.55 44.47 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 12.4 t 87.71 -50.04 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.2 38.03 1.95 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . -53.92 -22.78 20.74 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 30' ' ' VAL . 5.4 mt-30 60.96 -122.76 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 30' ' ' VAL . 55.3 t -145.56 55.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 120.482 1.492 . . . . 0.0 109.908 176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 29.2 t70 -77.23 -7.94 56.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 58.6 m -102.24 -9.27 20.57 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.243 -0.911 . . . . 0.0 110.683 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 56.56 86.29 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 59.47 25.42 14.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 109.71 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -88.64 -114.97 1.29 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -161.56 17.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.508 -0.995 . . . . 0.0 112.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 10.0 p30 -59.24 -21.74 60.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.519 -1.363 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.63 42.83 3.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.428 -0.795 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -91.95 -48.25 6.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 0.0 109.549 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.43 127.73 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.435 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.674 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -168.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.072 -1.252 . . . . 0.0 108.795 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -173.64 120.22 0.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.592 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m -65.66 137.04 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 29.5 m -49.9 -38.31 35.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.24 50.81 0.41 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.73 -34.22 0.32 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.97 136.98 56.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -1.031 . . . . 0.0 109.741 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 17' ' ' ASN . 9.2 p -63.6 -39.1 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.688 -0.633 . . . . 0.0 109.598 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -144.08 98.06 3.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.677 . . . . 0.0 109.797 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -175.48 144.18 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 172.42 12.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.835 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.722 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -151.61 166.77 14.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 20' ' ' ILE . 29.9 Cg_endo -73.84 162.66 38.87 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.582 1.522 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.82 71.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.984 0.897 . . . . 0.0 109.782 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.18 -39.35 92.39 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.479 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.2 m95 -76.35 -6.84 53.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.18 -0.95 . . . . 0.0 110.968 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 1.5 tpt180 -70.95 141.36 51.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 2.0 t 85.35 -51.13 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.51 -79.37 0.45 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 74.87 -6.85 24.19 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.626 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER 53.09 -112.37 0.69 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 29' ' ' GLN . 38.4 t -151.04 66.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.431 1.11 . . . . 0.0 108.423 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 25.5 t0 -97.58 24.88 6.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 20' ' ' ILE . 68.7 m -136.6 13.25 3.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.687 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 39.23 78.62 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 O-C-N 121.771 -0.581 . . . . 0.0 111.257 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 23.04 10.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.736 . . . . 0.0 109.251 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.27 -104.12 0.1 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.33 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -1.028 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 6.5 p30 -55.17 -23.14 20.15 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.755 -1.216 . . . . 0.0 110.012 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -127.25 46.26 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -114.27 -42.7 3.3 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.587 -0.696 . . . . 0.0 109.94 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.87 -40.97 34.77 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 26' ' ' CYS . 34.6 t . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 9.0 tp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.17 43.32 14.2 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.416 -0.803 . . . . 0.0 109.514 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.32 152.06 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.499 -0.751 . . . . 0.0 109.967 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.5 p -123.84 156.27 36.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.603 -0.686 . . . . 0.0 109.324 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.42 22.52 15.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.541 -0.724 . . . . 0.0 109.975 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.4 mttt 58.1 -170.16 0.11 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.275 -0.891 . . . . 0.0 109.87 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m -102.91 140.54 37.05 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.466 -0.771 . . . . 0.0 109.608 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 112.53 -27.11 10.21 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.88 -165.41 1.34 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.451 -1.029 . . . . 0.0 109.293 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE1' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -172.99 109.14 0.18 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.6 p -68.54 120.28 14.34 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.505 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 28.5 t -49.28 -65.4 0.57 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 110.833 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.57 100.36 0.18 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.4 25.89 72.62 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 58.33 72.96 0.49 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.387 -1.067 . . . . 0.0 109.916 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 17' ' ' ASN . 9.9 p -57.35 -23.6 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.052 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' CG ' HG13 ' A' ' 16' ' ' VAL . 3.1 p30 179.68 -35.36 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.354 -0.841 . . . . 0.0 109.83 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -155.45 -175.63 5.53 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.426 -0.796 . . . . 0.0 109.61 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.23 175.35 6.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.669 -0.644 . . . . 0.0 109.322 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 24' ' ' TRP . 37.8 mm -130.28 139.8 36.71 Favored Pre-proline 0 N--CA 1.492 1.63 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 29.8 Cg_endo -71.06 159.1 53.39 Favored 'Trans proline' 0 C--N 1.323 -0.813 0 C-N-CA 121.414 1.409 . . . . 0.0 110.686 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -58.35 -26.64 63.37 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.553 -0.717 . . . . 0.0 109.073 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -68.05 -39.34 83.03 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.707 -0.621 . . . . 0.0 109.484 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.549 ' CE3' ' HB2' ' A' ' 31' ' ' ASP . 11.9 m95 -81.37 -3.99 54.39 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.491 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 24.9 tpt180 -76.35 148.92 37.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.388 -1.445 . . . . 0.0 107.504 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 5.1 t 86.27 -56.32 0.06 Allowed 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.47 -76.17 0.47 Allowed 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.89 -18.45 39.61 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.5 OUTLIER 57.25 -111.32 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.653 ' O ' HG12 ' A' ' 30' ' ' VAL . 71.0 t -148.43 53.67 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 122.551 1.167 . . . . 0.0 108.862 174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 7.7 t70 -73.54 -9.12 58.35 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 176.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HA ' HG11 ' A' ' 16' ' ' VAL . 61.1 m -92.51 -13.28 30.05 Favored 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.275 -0.891 . . . . 0.0 110.314 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 60.42 -90.4 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.376 -0.828 . . . . 0.0 109.019 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -107.11 38.95 1.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.064 -1.023 . . . . 0.0 108.76 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.48 -136.23 5.4 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.93 68.48 0.18 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.571 -0.958 . . . . 0.0 110.538 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.4 -33.22 19.92 Favored 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.197 -0.939 . . . . 0.0 109.852 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -98.83 65.2 1.51 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.324 0.583 . . . . 0.0 109.697 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -101.72 62.07 0.91 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.17 105.54 1.37 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.412 -179.954 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 16.5 mt . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.7 m -129.23 102.06 6.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.536 -0.727 . . . . 0.0 109.564 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.2 p -58.79 101.13 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.563 -0.71 . . . . 0.0 109.548 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.402 ' O ' ' CB ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -144.26 167.28 22.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.661 -0.649 . . . . 0.0 109.267 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 4' ' ' THR . 21.1 m 84.05 -51.36 0.13 Allowed 'General case' 0 N--CA 1.509 2.509 0 C-N-CA 122.663 0.385 . . . . 0.0 110.685 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.2 mttt 67.11 -166.14 0.21 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.244 -0.91 . . . . 0.0 108.929 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.1 p -77.22 152.94 34.51 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.433 -0.792 . . . . 0.0 109.894 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 106.05 -19.75 37.21 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.4 -163.38 1.04 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -1.076 . . . . 0.0 109.552 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.645 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -169.93 127.26 0.87 Allowed 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.199 -0.601 . . . . 0.0 109.937 178.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.0 t -70.51 136.89 49.74 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.698 ' SG ' HD11 ' A' ' 20' ' ' ILE . 82.4 m -47.15 -60.91 2.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.345 -0.847 . . . . 0.0 110.781 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.32 -47.04 0.03 OUTLIER Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -113.57 136.82 13.67 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 -71.89 98.41 2.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.579 -0.954 . . . . 0.0 109.454 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 16' ' ' VAL . 47.5 t -139.54 49.63 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 O-C-N 121.548 -0.72 . . . . 0.0 109.694 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 59.69 59.9 2.39 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.367 -0.833 . . . . 0.0 109.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -166.37 103.35 0.62 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.405 -0.809 . . . . 0.0 109.079 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.1 p -117.8 169.35 9.68 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.78 0.8 . . . . 0.0 110.311 -179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.734 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.13 166.8 15.79 Favored Pre-proline 0 N--CA 1.497 1.912 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.5 Cg_endo -74.71 167.69 26.52 Favored 'Trans proline' 0 C--N 1.317 -1.105 0 C-N-CA 121.482 1.455 . . . . 0.0 110.682 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.16 -25.93 65.51 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -71.31 -21.61 62.04 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.522 -0.736 . . . . 0.0 109.892 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.611 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 8.1 m95 -91.32 20.84 4.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.891 . . . . 0.0 110.071 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 10' ' ' PHE . 12.1 mmm-85 -97.28 139.22 33.57 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.427 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 21.3 m 86.72 -54.64 0.06 Allowed 'General case' 0 N--CA 1.514 2.748 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 -177.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -93.74 -76.24 0.48 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 24' ' ' TRP . . . 69.96 0.3 26.3 Favored Glycine 0 N--CA 1.487 2.084 0 CA-C-O 119.17 -0.794 . . . . 0.0 111.809 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 52.49 -120.2 1.63 Allowed 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 -176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 29' ' ' GLN . 25.5 t -149.96 68.09 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 120.068 1.304 . . . . 0.0 108.885 174.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.94 26.25 5.94 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.0 m -134.61 178.49 6.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.31 -0.869 . . . . 0.0 109.839 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.4 -78.37 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -100.9 40.16 1.31 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.479 -0.763 . . . . 0.0 109.175 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.48 49.45 76.91 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -83.07 -3.13 56.96 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.671 -0.899 . . . . 0.0 110.449 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.27 -25.71 10.1 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.035 -1.04 . . . . 0.0 109.967 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -120.37 63.02 0.85 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.655 -0.653 . . . . 0.0 109.412 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.71 -55.6 4.34 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.417 -0.802 . . . . 0.0 109.678 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.48 -47.53 6.35 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.473 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m 58.67 91.19 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.311 -0.868 . . . . 0.0 109.723 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.46 HG13 ' HD3' ' A' ' 6' ' ' LYS . 9.0 p -58.42 153.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.473 -0.767 . . . . 0.0 109.957 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -140.18 142.99 35.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.595 -0.691 . . . . 0.0 109.589 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.3 m 59.22 80.45 0.19 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.792 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HD3' HG13 ' A' ' 3' ' ' VAL . 5.3 pttm -137.42 63.78 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.426 -0.796 . . . . 0.0 109.663 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.85 -73.17 0.09 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.555 -0.716 . . . . 0.0 109.218 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.86 24.7 2.27 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -92.9 -168.76 2.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -1.043 . . . . 0.0 109.243 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -173.2 121.91 0.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 p -69.57 135.86 50.57 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.547 ' SG ' HD11 ' A' ' 20' ' ' ILE . 67.9 m -47.16 -67.83 0.24 Allowed 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.484 -0.76 . . . . 0.0 111.095 -178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -96.5 -89.95 1.82 Allowed Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -158.82 32.09 0.47 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.5 mmt180 -125.97 160.57 29.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.591 -0.946 . . . . 0.0 109.423 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 16' ' ' VAL . 7.2 p -89.44 57.17 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 O-C-N 121.648 -0.657 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -105.1 -42.02 5.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.406 -0.809 . . . . 0.0 109.748 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 ttt85 -142.88 -178.94 6.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.514 -0.741 . . . . 0.0 109.77 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.58 156.02 40.56 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.655 -0.653 . . . . 0.0 109.556 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.735 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -150.21 163.85 22.81 Favored Pre-proline 0 N--CA 1.501 2.122 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.735 ' HD2' HG22 ' A' ' 20' ' ' ILE . 30.7 Cg_endo -74.31 162.0 39.3 Favored 'Trans proline' 0 C--N 1.324 -0.728 0 C-N-CA 122.003 1.802 . . . . 0.0 111.21 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -59.24 -28.8 67.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.689 -0.632 . . . . 0.0 109.708 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -68.0 -38.56 82.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.552 -0.718 . . . . 0.0 109.622 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.4 m95 -75.36 -5.69 46.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.471 -0.768 . . . . 0.0 110.05 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 28.1 tpt180 -71.98 143.19 49.31 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.413 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 17.9 m 85.39 -56.25 0.09 Allowed 'General case' 0 N--CA 1.51 2.562 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -96.29 -78.14 0.47 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.9 -1.18 40.85 Favored Glycine 0 N--CA 1.487 2.097 0 CA-C-O 119.107 -0.829 . . . . 0.0 112.086 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.704 ' O ' HG23 ' A' ' 30' ' ' VAL . 5.1 mt-30 52.49 -110.58 0.53 Allowed 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -176.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 29' ' ' GLN . 12.9 t -154.23 72.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 122.371 1.081 . . . . 0.0 108.575 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.451 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 37.8 t70 -104.56 31.59 4.6 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 72.1 m -130.35 172.51 11.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.677 -0.639 . . . . 0.0 110.322 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -58.2 -39.25 78.49 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.598 -0.689 . . . . 0.0 110.572 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -139.24 31.08 2.16 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.424 -0.797 . . . . 0.0 109.711 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.01 41.84 92.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -10.93 59.86 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -1.009 . . . . 0.0 109.762 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.5 p30 -51.6 -26.01 8.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.935 -1.103 . . . . 0.0 110.178 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -97.24 54.56 1.23 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.66 55.26 2.15 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.431 -0.793 . . . . 0.0 109.63 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.35 127.21 0.69 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.489 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -167.8 138.09 2.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.389 -0.819 . . . . 0.0 109.79 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.0 p -57.45 -24.59 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.543 -0.723 . . . . 0.0 110.073 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.1 -90.55 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.471 -0.768 . . . . 0.0 110.733 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 57.48 34.28 24.4 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.968 -1.082 . . . . 0.0 109.28 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.02 -161.97 0.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 p -118.63 162.69 17.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.387 -0.82 . . . . 0.0 109.97 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.29 25.15 68.11 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -109.76 -168.4 1.32 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.432 -1.04 . . . . 0.0 109.212 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.675 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -176.37 133.74 0.23 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 120.019 -0.673 . . . . 0.0 109.628 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -81.06 138.17 35.99 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.711 ' SG ' HD11 ' A' ' 20' ' ' ILE . 59.1 m -48.4 -38.34 19.31 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.333 -0.855 . . . . 0.0 110.386 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.15 -125.2 2.45 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.04 -105.42 0.01 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -135.67 53.97 1.93 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.569 -0.959 . . . . 0.0 109.514 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.9 t -59.0 -75.04 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.408 -0.808 . . . . 0.0 109.95 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 179.86 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.413 -0.804 . . . . 0.0 109.711 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.04 158.7 32.36 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.643 -0.661 . . . . 0.0 110.127 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 158.21 44.85 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.711 HD11 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -150.83 163.83 22.44 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.366 -0.834 . . . . 0.0 108.791 -179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.655 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.7 Cg_endo -74.77 164.2 34.12 Favored 'Trans proline' 0 C--N 1.322 -0.837 0 C-N-CA 121.939 1.759 . . . . 0.0 110.715 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -27.94 69.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.601 -0.687 . . . . 0.0 109.189 179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -66.29 -37.19 84.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.584 -0.698 . . . . 0.0 109.588 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.1 m95 -76.35 -9.99 59.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.419 -0.801 . . . . 0.0 110.219 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.464 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.1 tpt180 -70.73 146.04 50.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' N ' ' HG3' ' A' ' 25' ' ' ARG . 22.6 m 85.88 -58.78 0.07 Allowed 'General case' 0 N--CA 1.511 2.606 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -91.25 -77.85 0.41 Allowed 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 79.85 -8.84 48.04 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.541 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 30' ' ' VAL . 3.1 mt-30 55.97 -113.18 0.76 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 -175.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.629 ' O ' HG12 ' A' ' 30' ' ' VAL . 37.3 t -151.09 63.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 122.548 1.166 . . . . 0.0 108.48 174.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.449 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 27.2 t70 -84.56 2.31 41.86 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.473 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.5 m -136.41 24.2 3.2 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.0 -1.062 . . . . 0.0 110.112 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.26 63.56 2.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.428 -0.795 . . . . 0.0 110.426 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.27 24.84 4.0 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.249 -0.907 . . . . 0.0 109.502 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.95 -92.55 0.04 OUTLIER Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.4 p -145.09 0.84 0.95 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.966 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -61.39 -24.01 66.2 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.472 -1.393 . . . . 0.0 108.94 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -115.26 40.99 2.54 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.85 -64.99 1.07 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.656 -0.653 . . . . 0.0 109.997 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -164.3 128.36 1.8 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.405 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.49 HD13 ' HA ' ' A' ' 1' ' ' LEU . 3.2 mm? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -116.84 79.39 1.32 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.549 -0.719 . . . . 0.0 109.344 179.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 3' ' ' VAL . 10.8 p 40.5 35.06 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.019 0.438 . . . . 0.0 112.061 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 p -143.45 133.79 24.63 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.599 -0.688 . . . . 0.0 109.778 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HB2' ' CB ' ' A' ' 9' ' ' ASP . 26.3 p 35.68 69.74 0.17 Allowed 'General case' 0 N--CA 1.511 2.616 0 CA-C-O 121.247 0.546 . . . . 0.0 112.26 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 pttt -95.68 53.1 1.41 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.329 -0.857 . . . . 0.0 109.455 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.8 m -146.53 77.24 1.47 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.0 109.584 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.23 18.5 60.63 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' CB ' ' HB2' ' A' ' 5' ' ' CYS . 8.7 m-20 -105.43 -167.86 1.38 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -1.085 . . . . 0.0 108.847 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -172.95 125.91 0.45 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.6 178.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 p -67.24 130.63 43.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.601 ' SG ' HD11 ' A' ' 20' ' ' ILE . 60.1 m -51.05 -46.92 61.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.271 -0.893 . . . . 0.0 110.314 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 157.42 51.79 0.01 OUTLIER Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -163.92 -166.21 22.42 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.459 ' O ' HG12 ' A' ' 16' ' ' VAL . 9.7 mmt180 -102.21 122.83 44.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.56 -0.965 . . . . 0.0 109.728 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.576 ' O ' HG22 ' A' ' 16' ' ' VAL . 10.6 p 41.05 34.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -77.38 -66.86 0.78 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.436 -0.79 . . . . 0.0 108.923 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -171.73 141.75 1.47 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 54.8 m -99.4 169.51 9.28 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.483 -0.761 . . . . 0.0 110.369 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.659 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -152.03 169.87 8.84 Favored Pre-proline 0 N--CA 1.5 2.028 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.63 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.4 Cg_endo -75.5 163.85 33.51 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 121.975 1.783 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -61.78 -28.21 69.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.692 -0.63 . . . . 0.0 109.524 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -65.84 -44.21 86.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.58 -0.7 . . . . 0.0 109.672 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.519 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.7 m95 -70.73 -9.43 57.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.474 -0.766 . . . . 0.0 110.185 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.487 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 3.0 tpt85 -69.25 143.15 54.0 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.8 t 84.93 -57.47 0.09 Allowed 'General case' 0 N--CA 1.511 2.576 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.88 -78.69 0.44 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.14 -2.49 35.3 Favored Glycine 0 N--CA 1.487 2.042 0 CA-C-O 119.337 -0.702 . . . . 0.0 112.034 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.678 ' O ' HG23 ' A' ' 30' ' ' VAL . 1.8 mt-30 55.68 -114.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 -176.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 29' ' ' GLN . 14.8 t -153.0 71.37 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 119.631 1.105 . . . . 0.0 108.279 174.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 23.4 t0 -96.84 20.49 10.95 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.397 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.4 m -156.51 101.77 2.03 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.11 -0.994 . . . . 0.0 111.43 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 50.19 -148.31 0.32 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.391 -0.818 . . . . 0.0 109.966 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -54.4 -24.61 20.52 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.899 -1.126 . . . . 0.0 109.786 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.25 73.36 0.07 OUTLIER Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 39' ' ' GLN . 2.4 p -91.8 -13.77 30.91 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.357 -1.084 . . . . 0.0 109.541 178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 1.4 p30 -54.53 -30.04 52.58 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.607 -1.308 . . . . 0.0 108.61 177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.88 49.58 0.93 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 36' ' ' SER . 3.2 tt0 -101.03 71.83 1.43 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.84 84.73 1.55 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.902 -1.046 . . . . 0.0 109.528 -179.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.698 ' N ' HD13 ' A' ' 1' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.128 0.489 . . . . 0.0 109.901 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.6 p -118.54 -43.6 2.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.473 -0.767 . . . . 0.0 109.279 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.04 -25.55 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.623 -0.673 . . . . 0.0 109.973 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 50.94 -170.94 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.266 -0.896 . . . . 0.0 110.324 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 60.83 22.84 12.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.632 -0.667 . . . . 0.0 110.134 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.89 -161.75 0.25 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.231 -0.918 . . . . 0.0 109.67 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.7 m -100.66 166.99 10.61 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.554 -0.716 . . . . 0.0 109.417 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.11 40.85 99.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.03 -172.3 4.08 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.537 -0.978 . . . . 0.0 108.624 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -177.6 135.56 0.18 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.52 -0.738 . . . . 0.0 109.747 178.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 p -87.66 123.08 32.13 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.744 ' HB3' HD11 ' A' ' 20' ' ' ILE . 7.1 p -52.45 -35.89 53.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.352 -0.843 . . . . 0.0 110.101 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -176.09 114.4 0.48 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.89 -171.31 35.14 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.1 mtm180 -109.55 79.16 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.559 -0.965 . . . . 0.0 109.432 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 16' ' ' VAL . 13.9 p -94.93 26.92 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 121.512 -0.743 . . . . 0.0 110.154 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.72 31.83 18.46 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.317 -0.865 . . . . 0.0 109.644 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HB2' HG13 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -140.09 112.31 7.71 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.9 p -109.42 172.41 6.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.562 -0.711 . . . . 0.0 110.392 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -149.14 163.45 25.28 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 179.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.687 ' HD2' HG22 ' A' ' 20' ' ' ILE . 31.0 Cg_endo -75.3 163.18 35.15 Favored 'Trans proline' 0 C--N 1.32 -0.922 0 C-N-CA 121.882 1.721 . . . . 0.0 110.794 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.76 -26.67 65.87 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.568 -0.708 . . . . 0.0 109.383 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -67.34 -41.75 84.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.734 -0.603 . . . . 0.0 109.7 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.515 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.0 m95 -72.56 -11.29 60.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.474 -0.766 . . . . 0.0 110.365 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.466 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 9.0 tpt180 -69.51 139.96 53.9 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 0.5 OUTLIER 85.99 -54.84 0.07 Allowed 'General case' 0 N--CA 1.511 2.591 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 -178.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -102.37 -78.98 0.53 Allowed 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 59.75 12.52 21.01 Favored Glycine 0 N--CA 1.487 2.066 0 CA-C-O 119.043 -0.865 . . . . 0.0 111.433 178.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.4 OUTLIER 51.87 -119.24 1.42 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -176.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 30' ' ' VAL . 40.7 t -149.92 59.12 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-O 122.771 1.272 . . . . 0.0 108.254 173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 12.4 t0 -65.14 -16.17 63.21 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.853 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.41 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 1.4 m -117.16 95.99 5.23 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.313 -0.867 . . . . 0.0 109.927 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -67.68 130.01 41.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.94 24.68 14.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.444 -0.785 . . . . 0.0 109.241 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -108.77 -120.63 4.41 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.48 32.94 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.303 -1.116 . . . . 0.0 111.634 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.2 -23.85 16.08 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.603 -1.311 . . . . 0.0 109.544 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -130.26 60.26 1.62 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.535 -0.728 . . . . 0.0 109.15 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -99.28 -51.7 3.73 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.342 -0.849 . . . . 0.0 109.851 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.26 47.87 2.64 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.3 t . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.456 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 t -157.67 30.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.552 -0.718 . . . . 0.0 109.399 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.6 p -77.77 -14.76 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 O-C-N 121.626 -0.671 . . . . 0.0 110.494 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.58 -78.83 0.58 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 0.0 110.102 -179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.12 59.79 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.468 -0.77 . . . . 0.0 109.758 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mmtt 57.64 -174.8 0.08 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.295 -0.878 . . . . 0.0 110.031 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 82.7 p -102.38 44.6 1.0 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.497 -0.752 . . . . 0.0 109.655 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.48 -51.42 0.01 OUTLIER Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -70.08 -164.92 0.08 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.643 -0.916 . . . . 0.0 108.762 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.508 ' CD2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -174.54 120.72 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.651 -0.655 . . . . 0.0 109.691 178.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.5 t -70.68 134.01 47.14 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 82.2 m -46.91 -44.82 20.14 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.562 -0.711 . . . . 0.0 111.222 -178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.44 43.82 0.02 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 143.19 -174.25 23.87 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 58.68 104.04 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.6 -0.941 . . . . 0.0 110.084 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.66 -25.88 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 0.0 110.294 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -89.72 162.9 15.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.33 -0.856 . . . . 0.0 110.4 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 64.23 138.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.749 -0.594 . . . . 0.0 110.251 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.2 -178.03 5.85 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.58 -0.7 . . . . 0.0 109.269 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.512 HG22 ' HB2' ' A' ' 24' ' ' TRP . 41.1 mm -133.58 141.9 41.91 Favored Pre-proline 0 N--CA 1.497 1.918 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' A' ' 24' ' ' TRP . 28.4 Cg_endo -69.42 157.81 59.7 Favored 'Trans proline' 0 C--N 1.325 -0.661 0 C-N-CA 121.451 1.434 . . . . 0.0 111.304 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 pp0? -53.41 -36.79 61.88 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 122.074 0.94 . . . . 0.0 109.621 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -63.39 -41.1 98.75 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.382 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.538 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 12.4 m95 -78.73 -3.53 44.68 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.065 -1.022 . . . . 0.0 110.342 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HA ' ' CE2' ' A' ' 10' ' ' PHE . 15.9 tpt180 -75.55 151.13 37.96 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 41' ' ' CYS . 24.0 m 85.82 -55.39 0.08 Allowed 'General case' 0 N--CA 1.51 2.546 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 -178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -89.55 -73.9 0.5 Allowed 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . 94.31 -26.9 15.21 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 30' ' ' VAL . 3.3 mt-30 56.33 -117.24 1.07 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 103.859 -2.645 . . . . 0.0 103.859 -176.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' HG12 ' A' ' 30' ' ' VAL . 53.6 t -147.63 55.83 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 122.936 1.351 . . . . 0.0 107.46 174.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB2' ' CE3' ' A' ' 24' ' ' TRP . 0.3 OUTLIER -90.3 15.02 11.23 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.026 178.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.0 m -126.97 12.69 7.25 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.248 -0.908 . . . . 0.0 109.844 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 50.96 62.13 2.88 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.159 -0.963 . . . . 0.0 109.609 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.32 26.48 15.34 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.42 -111.0 0.04 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.55 26.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.671 -0.9 . . . . 0.0 110.971 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -52.98 -30.16 33.34 Favored 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.96 -1.088 . . . . 0.0 109.716 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.46 75.26 8.43 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -102.67 -40.36 6.65 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.39 -0.819 . . . . 0.0 109.542 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.55 120.83 0.71 Allowed Glycine 0 N--CA 1.494 2.539 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HB2' ' HA ' ' A' ' 26' ' ' CYS . 20.0 t . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.577 -0.954 . . . . 0.0 109.42 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 1' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 p 55.69 178.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.661 -0.65 . . . . 0.0 110.377 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.496 HG22 HG23 ' A' ' 4' ' ' THR . 13.3 p -70.26 164.97 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.704 -0.622 . . . . 0.0 110.251 -179.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.496 HG23 HG22 ' A' ' 3' ' ' VAL . 10.6 p 57.02 -167.26 0.12 Allowed 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.421 0.629 . . . . 0.0 110.401 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -93.64 24.31 4.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.665 -0.647 . . . . 0.0 110.147 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.06 177.03 0.09 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.318 -0.863 . . . . 0.0 109.732 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -89.83 165.07 14.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.599 -0.688 . . . . 0.0 110.113 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.03 83.56 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.67 -163.33 1.04 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.096 -1.238 . . . . 0.0 109.215 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.624 ' CZ ' HD12 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -172.16 133.49 0.69 Allowed 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.934 178.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.6 t -76.09 138.71 40.98 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.563 ' SG ' HD11 ' A' ' 20' ' ' ILE . 53.9 m -48.04 -58.45 4.45 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.301 -0.874 . . . . 0.0 110.738 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.04 64.92 0.05 OUTLIER Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 112.36 45.28 0.8 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -162.95 75.1 0.4 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.627 -0.925 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.0 p -59.3 -26.32 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.47 -0.769 . . . . 0.0 110.009 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -62.7 -37.52 86.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.498 -0.751 . . . . 0.0 110.012 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 21.3 ttm-85 -107.4 128.21 54.27 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.393 -0.817 . . . . 0.0 109.921 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 22.6 p -120.49 168.74 11.02 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.518 -0.739 . . . . 0.0 110.03 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.682 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -146.28 167.73 13.3 Favored Pre-proline 0 N--CA 1.503 2.182 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.2 Cg_endo -74.36 163.55 36.04 Favored 'Trans proline' 0 C--N 1.321 -0.908 0 C-N-CA 121.593 1.529 . . . . 0.0 110.62 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -64.29 -27.02 68.75 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.65 -0.656 . . . . 0.0 109.305 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -70.31 -31.37 68.66 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 109.917 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.579 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 9.2 m95 -80.94 2.19 27.82 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.35 -0.844 . . . . 0.0 110.453 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HD3' ' CD1' ' A' ' 10' ' ' PHE . 6.2 tpt180 -77.47 138.84 39.47 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 1.9 t 85.38 -51.43 0.08 Allowed 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.82 -77.74 0.47 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 72.99 -0.16 47.85 Favored Glycine 0 N--CA 1.488 2.105 0 CA-C-O 119.111 -0.827 . . . . 0.0 112.106 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.675 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.5 OUTLIER 52.55 -113.49 0.76 Allowed 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 -176.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 29' ' ' GLN . 16.4 t -152.33 69.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 122.478 1.132 . . . . 0.0 108.611 174.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 36.9 t70 -100.99 23.57 10.53 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.306 -0.861 . . . . 0.0 108.863 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.9 m -132.81 -165.13 1.56 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 109.93 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.4 -80.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.586 -0.697 . . . . 0.0 109.759 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -106.54 28.53 7.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.344 -0.847 . . . . 0.0 109.565 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.13 41.41 7.07 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.04 -22.52 64.95 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.538 -0.977 . . . . 0.0 109.517 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p30 -53.76 -25.69 20.09 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.079 -1.013 . . . . 0.0 109.598 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -115.14 48.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.57 108.05 19.56 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.47 -0.769 . . . . 0.0 110.231 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.74 -66.22 1.39 Allowed Glycine 0 N--CA 1.494 2.555 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 26' ' ' CYS . 38.6 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.87 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -143.67 24.94 1.68 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 109.864 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 4' ' ' THR . 9.2 p -62.58 125.68 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.412 -0.805 . . . . 0.0 109.471 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -160.23 -175.69 5.2 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.509 -0.744 . . . . 0.0 109.464 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 86.0 m 57.93 82.53 0.13 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.5 -0.75 . . . . 0.0 109.808 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.78 94.87 3.95 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.597 -0.689 . . . . 0.0 109.84 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.47 111.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.488 -0.758 . . . . 0.0 109.665 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.42 26.01 14.7 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.82 -168.04 1.76 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.408 -1.054 . . . . 0.0 109.034 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.719 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -165.93 108.27 0.76 Allowed 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.78 108.33 1.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.513 ' HB2' HD11 ' A' ' 20' ' ' ILE . 35.1 t -49.54 -56.85 8.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.749 -0.594 . . . . 0.0 110.826 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 126.63 174.99 13.98 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.04 -168.57 43.12 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.16 -173.14 1.0 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.581 -0.952 . . . . 0.0 109.25 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.4 p 37.86 94.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.189 0.995 . . . . 0.0 111.8 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.01 98.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 121.366 0.603 . . . . 0.0 110.928 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.68 112.58 19.46 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.7 p -93.06 169.35 10.48 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.419 -0.801 . . . . 0.0 110.262 -179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.719 HD12 ' CE2' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -147.78 175.11 2.9 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.56 ' CD ' HG22 ' A' ' 20' ' ' ILE . 32.6 Cg_endo -77.02 152.63 31.77 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 121.561 1.508 . . . . 0.0 110.015 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.34 -19.64 56.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.516 -0.74 . . . . 0.0 109.971 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -77.18 -31.77 55.67 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.463 -0.773 . . . . 0.0 110.332 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 31' ' ' ASP . 5.0 m95 -73.68 -6.05 44.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 110.847 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HG2' ' CG ' ' A' ' 10' ' ' PHE . 3.1 mmm-85 -70.11 131.55 44.47 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 25' ' ' ARG . 12.4 t 87.71 -50.04 0.04 OUTLIER 'General case' 0 N--CA 1.516 2.83 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -104.2 38.03 1.95 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 37' ' ' ASP . . . -53.92 -22.78 20.74 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 30' ' ' VAL . 5.4 mt-30 60.96 -122.76 0.89 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 103.58 -2.748 . . . . 0.0 103.58 -176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.637 ' O ' HG12 ' A' ' 30' ' ' VAL . 55.3 t -145.56 55.5 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 120.482 1.492 . . . . 0.0 109.908 176.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 29.2 t70 -77.23 -7.94 56.74 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HA3' ' A' ' 35' ' ' GLY . 58.6 m -102.24 -9.27 20.57 Favored 'General case' 0 N--CA 1.483 1.221 0 O-C-N 121.243 -0.911 . . . . 0.0 110.683 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 56.56 86.29 0.07 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.0 109.447 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.4 m-20 59.47 25.42 14.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.554 -0.716 . . . . 0.0 109.71 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 32' ' ' CYS . . . -88.64 -114.97 1.29 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 p -161.56 17.55 0.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.508 -0.995 . . . . 0.0 112.107 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.467 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 10.0 p30 -59.24 -21.74 60.03 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.519 -1.363 . . . . 0.0 109.793 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -126.63 42.83 3.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.428 -0.795 . . . . 0.0 109.224 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -91.95 -48.25 6.86 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.459 -0.775 . . . . 0.0 109.549 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.43 127.73 3.74 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.435 -179.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.8 mp . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -64.76 0.84 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.6 -0.687 . . . . 0.0 109.307 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.504 ' O ' HG13 ' A' ' 3' ' ' VAL . 9.8 p -58.3 121.82 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.534 -0.729 . . . . 0.0 109.862 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.23 -50.33 1.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.496 -0.753 . . . . 0.0 109.326 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.32 -73.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.656 -0.653 . . . . 0.0 109.315 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.05 -45.94 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.527 -0.733 . . . . 0.0 109.569 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.0 t -176.03 -66.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.512 -0.743 . . . . 0.0 110.498 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -102.22 -3.96 50.73 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 120.243 -0.98 . . . . 0.0 111.156 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.38 -168.47 0.32 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.072 -1.252 . . . . 0.0 108.795 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.578 ' CE2' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -173.64 120.22 0.31 Allowed 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.592 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.2 m -65.66 137.04 57.06 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 10' ' ' PHE . 29.5 m -49.9 -38.31 35.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.45 -0.781 . . . . 0.0 110.131 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.24 50.81 0.41 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.73 -34.22 0.32 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 mmt180 -66.97 136.98 56.16 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.447 -1.031 . . . . 0.0 109.741 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 17' ' ' ASN . 9.2 p -63.6 -39.1 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.688 -0.633 . . . . 0.0 109.598 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -144.08 98.06 3.16 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.618 -0.677 . . . . 0.0 109.797 -179.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.1 ttm-85 -175.48 144.18 0.67 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.159 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -142.46 172.42 12.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.567 -0.708 . . . . 0.0 109.835 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.722 HG22 ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -151.61 166.77 14.46 Favored Pre-proline 0 N--CA 1.497 1.877 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.722 ' HD2' HG22 ' A' ' 20' ' ' ILE . 29.9 Cg_endo -73.84 162.66 38.87 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.582 1.522 . . . . 0.0 111.311 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.25 -36.82 71.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.984 0.897 . . . . 0.0 109.782 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -62.18 -39.35 92.39 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.479 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.545 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 11.2 m95 -76.35 -6.84 53.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.18 -0.95 . . . . 0.0 110.968 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.472 ' HD3' ' CG ' ' A' ' 10' ' ' PHE . 1.5 tpt180 -70.95 141.36 51.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HA ' ' CB ' ' A' ' 41' ' ' CYS . 2.0 t 85.35 -51.13 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -96.51 -79.37 0.45 Allowed 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' O ' ' CE3' ' A' ' 24' ' ' TRP . . . 74.87 -6.85 24.19 Favored Glycine 0 N--CA 1.487 2.079 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.885 177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.626 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.2 OUTLIER 53.09 -112.37 0.69 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 104.372 -2.455 . . . . 0.0 104.372 -176.305 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 29' ' ' GLN . 38.4 t -151.04 66.28 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 CA-C-O 122.431 1.11 . . . . 0.0 108.423 174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 24' ' ' TRP . 25.5 t0 -97.58 24.88 6.23 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' SG ' HD11 ' A' ' 20' ' ' ILE . 68.7 m -136.6 13.25 3.2 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.371 -0.831 . . . . 0.0 110.687 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 39.23 78.62 0.04 OUTLIER 'General case' 0 N--CA 1.513 2.707 0 O-C-N 121.771 -0.581 . . . . 0.0 111.257 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 58.78 23.04 10.75 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.523 -0.736 . . . . 0.0 109.251 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -75.27 -104.12 0.1 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -175.33 31.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.453 -1.028 . . . . 0.0 111.174 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' HB3' ' CD1' ' A' ' 20' ' ' ILE . 6.5 p30 -55.17 -23.14 20.15 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.755 -1.216 . . . . 0.0 110.012 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -127.25 46.26 2.56 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.472 -0.767 . . . . 0.0 109.354 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.8 tm0? -114.27 -42.7 3.3 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.587 -0.696 . . . . 0.0 109.94 -179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.87 -40.97 34.77 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.462 ' CB ' ' HA ' ' A' ' 26' ' ' CYS . 34.6 t . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.894 -179.828 . . . . . . . . 1 1 . 1 stop_ save_